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Bacteria that live in contact with eukaryotic hosts, whether as symbionts or as pathogens, 
have often evolved mechanisms to manipulate host cell behavior to their benefit. Various 
Gram-negative bacterial species employ a type III secretion (T3S) system that allows the 
translocation of effector proteins into host cells (Cornelis and Wolf-Watz, 1997; Galán and 
Collmer, 1999) (Figure 1.1). The targets and biochemical activities of these effectors widely 
vary within and between organisms. Frequently, cellular signaling pathways are manipulated 




The T3S machinery, termed injectisome, can directly translocate effector proteins from the 
bacterial cytosol into the host cytoplasm. It shares this feature with the Type IV and Type VI 
secretion systems (T4S, T6S, respectively; Figure 1.2). The overall structure of the T3S 
system is related to the T4S system (Cascales and Christie, 2003). Both involve a cytosolic 
ATPase, a core complex spanning both bacterial membranes (Kubori et al., 1998; Chandran et 
al., 2009; Fronzes et al., 2009b), and an extracellular appendix. However, at least the 
extracellular filament of the T4S system seems to assemble in a more transient way (Fronzes 
et al., 2009a; Sivanesan et al., 2010). In its outer membrane (OM) part, the T3S also displays 
Figure  1.1:  Function  of  the  bacterial  type  III  secretion  system 
(Cornelis, 2006). 
The  injectisome  is  a  large protein  complex  that  spans both bacterial 
membranes with ring‐shaped structures (blue) and contains cytosolic 
components (pink) as well as an extracellular hollow needle (rose). It 
is  formed  by  the  bacterium  in  the  host,  usually  induced  by 
temperature.  Upon  contact  with  a  host  cell,  a  translocation  pore 
(orange)  is  assembled  at  the needle  tip  (yellow) within  the host  cell 









When type III secretion systems were first analyzed in detail, the most striking observation 
was their close relationship to the bacterial flagellum (Fields et al., 1994; Woestyn et al., 
1994; Van Gijsegem et al., 1995). This became even more evident when the first partial 
structure of an injectisome, the needle complex (NC)1 of Salmonella enterica SPI-1, was 
visualized by electron microscopy (EM) (Kubori et al., 1998). The homology centers on the 
so-called basal body spanning both bacterial membranes, whereas the flagellum possesses 
additional proteins such as the motor / stator proteins for rotation, and the extracellular 
filament (Figure 1.3 a, b). 
The phylogenetic relationship between the flagellum and the injectisome is a matter of debate. 
While it seems evident that motility was beneficial for bacteria long before the advent of 
eukaryotic hosts that would have rendered translocation systems beneficial, phylogenetic 
studies suggest that both systems share a common ancestor, and have since evolved 
differently from each other (Gophna et al., 2003). 
A notable difference between various pathogenic T3S systems is the nature of the 
extracellular appendices (Cornelis and Van Gijsegem, 2000). Most injectisomes build a                                                         
1 Needle complex (NC): The part of an injectisome that can be purified and visualized in some bacteria. 
This part includes the needle and the transmembrane rings, but not the IM export machinery or the 










Bacterial  outer  membrane;  IM,  Bacterial  inner  membrane;  MM,  Mycomembrane;  MFP, 





The Plant Associated Microbe Gene Ontology (PAMGO)
project has been developing standardized terms for
describing biological processes and cellular components
that play important roles in the interactions of microbes
with each other and with host organisms, including ani-
mals as well as plants [1]. The central purpose of these
terms is to enable commonalities in function to be identi-
fied across broad taxonomic classes of organisms, includ-
ing both microbes and hosts. An important concept
underlying these terms is that they are agnostic of the out-
come of an interaction, which can be very context depend-
ent. The term "symbiosis" is used as a general description
of any intimate biotic interaction between an organism
such as a microbe with a larger host organism. The incor-
rect usage of symbiosis as a synonym for mutualism is
strongly discouraged. Thus most of the PAMGO terms
have as their parent "GO:0044403: symbiosis, encom-
passing mutualism through parasitism". The term
"GO:0009405 pathogenesis" can be used when there is
unequivocal evidence that a process is deleterious to the
host, but no detailed mechanistic terms are listed under
"GO:0009405 pathogenesis". This review provides a brief
survey of eight classes of secretion systems, then describes
Gene Ontology terms that are now available for annotat-
ing the secretion machineries, as well as missing terms
that still need to be added. The review concentrates on the
machinery of the protein secretion systems, rather than on
the secreted proteins, which are the subject of two accom-
panying reviews in this supplement [2,3].
Secretion systems
Figure 1 summarizes the main features of the known
secretion systems. In Gram-negative bacteria, some
secreted proteins are exported across the inner and outer
membranes in a single step via the type I, type III, Type IV
or type VI pathways. Other proteins are first exported into
the periplasmic space via the universal Sec or two-arginine
(Tat) pathways and then translocated across the outer
membrane via the type II, type V or less commonly, the
type I or type IV machinery. In Gram-positive bacteria,
secreted proteins are commonly translocated across the
single membrane by the Sec pathway or the two-arginine
(Tat) pathway. However, in Gram-positive bacteria such
as mycobacteria that have a hydrophobic, nearly imper-
meable cell wall, called the mycomembrane, a specialized
type VII secretion system translocates proteins across both
the membrane and the cell wall via a (still poorly-defined)
channel, but it is not known yet if this is a one-step or two-
step process.
General secretion and two-arginine (Tat) pathways
The general secretion (Sec) pathway and the two-arginine
or Tat translocation pathway are both universal to eubac-
teria, archaea and eukaryotes (reviewed in [4-6]). In
archaea and Gram-positive bacteria the two pathways are
responsible for secretion of proteins across the single
plasma membrane, while in Gram-negative bacteria they
are responsible for export of proteins into the periplasm.
The machinery of the Sec pathway recognizes a hydropho-
bic N-terminal leader sequence on proteins destined for
secretion, and translocates proteins in an unfolded state,
using ATP hydrolysis and a proton gradient for energy [4].
The machinery of the Tat secretion pathway recognizes a
motif rich in basic amino acid residues (S-R-R-x-F-L-K) in
the N-terminal region of large co-factor containing pro-
teins and translocates the proteins in a folded state using
only a proton gradient as an energy source [5].
A very detailed understanding of the Sec machinery has
been developed through 30 years' of genetic, biochemical
and biophysical studies, principally in E. coli [4]. The pro-
tein-conducting pore of the Sec translocase consists of a
membrane-embedded heterotrimer, SecY/SecE/SecG
(sec61!, sec61" and sec61# in eukaryotes). The cytoplas-
Summary of known bacterial secretion systemsFigure 1
Summary of known bacterial secretion systems. In this simplified view only the basics of each secretion system are 
sketched. HM: Host membrane; OM: outer membrane; IM: inner membrane; MM: mycomembrane; OMP: outer membrane 
protein; MFP: membrane fusion protein. ATPases and chaperones are shown in yellow.
Regulation and assembly of the type III secretion system of Yersinia enterocolitica 
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needle-like structure with a length between 40 and 80 nm (Cornelis, 2006) (Figure 1.3 b). As 
adaptation to their host cells, the injectisomes of enteropathogenic Escherichia coli (EPEC) 
contain a long filament on top of this needle, which is built by another protein (Knutton et al., 
1998; Daniell et al., 2001) (Figure 1.3 c). Likewise, plant pathogens express a protein forming 
a pilus with a length up to several µm to be able to penetrate the host cell wall (Roine et al., 




Based on protein homologies, T3S systems can be classified into different subfamilies 
(Cornelis, 2006). The Ysc system studied in this work is present in Yersinia spp., some 
Pseudomonas spp., and Aeromonas spp. Other well-studied systems are the injectisomes from 
Salmonella spp. SPI-12 and Shigella flexneri (“SPI-1-like”), and the injectisomes from EPEC, 
EHEC and Salmonella SPI-2 (“SPI-2-like”). Plant pathogens can possess two types of T3S 
systems (Hrp1 and Hrp2).                                                         
2 Salmonella spp. harbor two Salmonella pathogenicity islands (SPIs) each encoding a type III secretion 
system. SPI-1 is required for invasion, whereas systemic infections and intracellular accumulation of 
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Diameter 20 nm
Length 5–10 µm 
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Hook: 
Diameter  20 nm
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The needle complex is the part 
of the injectisome that was 
characterized in great detail by 
cryo-EM28,30,85. This structure 
contains neither the ATPase 
nor the putative C ring.
only three families: the Ysc injectisome of Y rsinia spp. 
is the archetype of one of these families, and similar 
injectisomes are found in Pseudomonas aeruginosa17 
and in the fish pathogen Aeromonas salmonicida18. The 
injectisomes from Shigella flexneri and S. typhimurium 
(encoded on SPI-1) are archetypal examples of a second 
family whose members are distributed primarily among 
the animal pathogens. Examples of the third family ar  
found in enteropathogenic (EPEC) and enterohaemor-
rhagic (EHEC) E cherichia coli, and in S. typhimurium 
(encoded on SPI-2). Injectisomes that occur in plant 
pathogens belong to two families (called Hrp1 and Hrp2 
in TABLE 2). It is not uncommon for the same patho-
genic bacterium to encode two injectisomes belonging 
to different families, each having a role at a different 
stage of the infection process. The best studied example 
is S. typhimurium; as alluded to above, this pathogen 
harbours two pathogenicity islands (SPI-1 and SPI-2), 
each of which encodes a different T3SS19,20.
Structure of the injectisome
Overview. The visualization by transmission electron 
microscopy (TEM) of the NC from S. typhimurium was 
a landmark achievement in the field13. Since then, the 
NCs from S. flexneri and EPEC have also been visualized 
using TEM21–27. N t surprisingly, the NCs from S. typh-
imurium SPI-1 and from S. flexneri seem very similar. 
The NC derived from the EPEC injectisome also looks 
similar, albeit smaller, despite the fact that this example 
belongs to a different family21. This finding indicates that 
the global architecture of NCs is conserved among the 
different injectisomes.
The NC consists of a cylindrical structure, similar to 
the flagellar basal body, composed of two pairs of rings 
that span the inner and outer bacterial membranes, joined 
together by a rod (FIG. 1). The discovery of this structure 
was consistent with previous observations indicating that 
the export of the effector proteins across the bacterial 
membranes and translocation through the eukaryotic 
membrane occurs in a single step. Depending on the fam-
ily of injectisomes, a hollow stiff needle (FIG. 2b), a filament 
(FIG. 2c) or a pilus (FIG. 2d) terminate the structure.
Single particle analysis using cryo-electron micro-
scopy (cryo-EM) allowed Blocker et al. to determine 
the structure of a purified NC from S. flexneri at high 
resolution28. This structure revealed, for the first time, 
a central channel of approximately 2–3 nm that extends 
from the bottom set of rings to the tip of the extracel-
lular needle (FIG. 2b). This channel size is too small to 
allow folded proteins to pass through the tube, and is 
consistent with previous observations indicating that 
proteins need to be unfolded to be exported29. Using 
cryo-EM, Marlovits et al. analysed the NC encoded on 
SPI-1 of S. typhimurium and observed some sample 
heterogeneity among the NCs30. The lower rings of 
the complexes in most of the samples had a rotational 
Figure 1 | Structure of the flagellum and the injectisomes. Schematic representation of the flagellum (a), Ysc 
injectisome (b), injectisome from EPECs (c) and the injectisome from plant pathogens (d). For the injectisomes, the C ring is 
represented by a dashed line as information on this component is still scarce. IM, inner membrane; OM, outer membrane; 
PG, peptidoglycan.
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While effector proteins are diverse and highly adapted to the specific lifestyle of the 
bacterium, the export apparatus itself is conserved among species (Cornelis, 2006), especially 
within the basal body. This part of the injectisome is thought to consist of at least nine 
different highly conserved proteins (YscC, J, N, Q, R, S, T, U, V in Yersinia) and three less-
conserved proteins (YscD, K, L in Yersinia). Table I shows an overview of these proteins and 










‐  YscC  InvG  MxiD  HrcC  Secretin 
Outer membrane 
FliG  YscD  PrgH  MxiG  HrcD  MS ring 
Inner membrane 
FliF  YscJ  PrgK  MxiJ  HrcJ  MS ring, lipoprotein 
Inner membrane 
‐  YscK  OrgA  MxiK  HrpD  Interacts with ATPase and 
putative C ring; cytosolic 
FliH  YscL  OrgB  MxiN  HrpE  Putative negative regulator 
of ATPase; cytosolic 








FliP  YscR  InvL/SpaP  Spa24  HrcR  Export apparatus 
Inner membrane  
(FliQ)  YscS  SpaQ  Spa9  HrcS  Export apparatus 
Inner membrane  
FliR  YscT  InvN/SpaR  Spa29  HrcT  Export apparatus 
Inner membrane  
FlhB  YscU  SpaS  Spa40  HrcU  Export apparatus* 
Inner membrane  













After the first visualization of a needle complex in Salmonella (Kubori et al., 1998), 
additional structures of NCs from Shigella (Tamano et al., 2000; Blocker et al., 2001) and 
EPEC (Daniell et al., 2001; Sekiya et al., 2001) were solved, and resolution could be 
increased by cryo-EM techniques and averaging (Marlovits et al., 2004; Marlovits et al., 
2006; Sani et al., 2006; Hodgkinson et al., 2009). In recent years, the availability of crystal 
structures of various T3S component domains (Yip et al., 2005; Zarivach et al., 2007; 
Zarivach et al., 2008; Spreter et al., 2009; Wiesand et al., 2009) has allowed to dock several 
of these structures into medium-resolution electron density maps obtained by EM, such that 
now parts of the system have been described at molecular resolution (Moraes et al., 2008; 
Spreter et al., 2009; Schraidt et al., 2010) (Figure 1.4). 
Most of this progress has been based on the purification of needle complexes. However, 
essential parts of the injectisome are missing from this structure, because they are either 
transiently connected with the needle complex or are lost during the purification procedure. 
For this reason, there is a bias in knowledge towards the structural components of the 
injectisome. In contrast, comparably little is known about assembly, function, and regulation 





Figure  1.4:  Modeling  of  protein 
crystal  structure  data  into  an 




and  its  components.  b  Crystal 
structures  of  basal  body 
components  and  their  proposed 
localization  within  the  basal  body. 
The  displayed  crystal  structures 
have  been  derived  from  different 
organisms (EscC and EscJ from EPEC, 




EM on the assembled T3SS has considerably advanced our under-
standing of its overall architecture, but the complexity and membrane-
spanning nature of this macromolecular assembly has hampered
structural characterization of the molecular details, essential to further
investigate this clinically important apparatus. The integrated
approach described here, of combining X-ray crystallography, EM,
molecular modeling, in vivo analysis and site-directed mutagenesis,
allowed us to begin a process of piecing together a structural picture of
the T3SS basal body.
RESULTS
Crystal structures of EscC21–174 and PrgH170–362
In the first stage of our analysis we have determined the crystal
structures of the periplasmic domains of two integral T3SS basal body
components: (i) the outer membrane secretin EscC from EPEC and
(ii) the inner membrane protein PrgH from S. typhimurium (Fig. 1b).
The crystal structure of the outer membrane secretin EscC21–174
monomer reveals a modular fold of two small domains (domain 1
(blue) contains residues 21–104 and domain 2 (orange) contains
residues 106–174) that are connected by a linker centered at residue
105 (Fig. 2a). The two domains are tilted toward each other and form
a prominent hydrophobic interface, comprising several aromatic
residues. Structure-based sequence analysis of EscC21–174 and other
T3SS species variants reveals a conservation of residues within the core
of the two domains as we l as a conservation of both the linker and the
interface of the two small domains, implying that the fold of the
N-terminal region of T3SS-specific secretins is highly analogous
(Supplementary Fig. 1 online). The structure of the inner membrane
PrgH170–362 monomer, shown in Figure 2c, also shows a modular
architecture of three topologically similar a/b domains (domain 1
(yellow) contains residues 170–224, domain 2 (green) contains resi-
dues 225–295 and domain 3 (orange) contains residues 296–362) that
are connected by short linkers. These modular domains together fold
into a ‘boot’-shaped structure (Fig. 2c).
EscC, PrgH and EscJ share a common fold
Despite a complete lack of detectable sequence identity, a comparative
structural analysis of the inner membrane PrgH170–362 reveals strong
similarity to the other inner membrane ring component EscJ/PrgK, as
well the outer membrane ring component EscC21–174 (ref. 8; Fig. 2).
Superposition of EscC21–174, PrgH170–362 and EscJ shows that the three
proteins that constitute the T3SS basal body rings share a similar
modular domain architecture with particular resemblance in the
domains shown in orange and green in Figure 2 (Supplementary
Fig. 2 online). The domains of EscC and EscJ depicted in orange
superimpose with a Dali Z-score of 4.8, the domains of PrgH and EscJ
shown in green superimpose with a Dali Z-score of 4.9 and the
orange-colored domain of PrgH superimposes with both EscC and
EscJ with lower structural homology (Z-scores of 3.9 and 3.2 respec-
tively). These particular domains have an analogous wedge-shaped
structure, with two a-helices folding against a b-sheet. In EscJ,
these domains mediate intersubunit interactions, assembling into a
24-subunit homo-oligomeric symmetrical structure8,9 (Figs. 1b and
2b). This strong similarity in fold and architecture between the three
proteins suggests the conservation of a wedge-shaped fold that
potentially provides a common ring-building motif for the assembly
of the symmetrical ring structures that constitute the T3SS basal body.
At the same time, the sequence variation between the three individu-
ally conserved ring family proteins allows for unique differences that
mediate formation of rings with varying oligomerization number,
overall size and distinct surface features necessary for T3SS assembly
and function.
Prediction of EscC21–174 ring structures
To investigate this appealing hypothesis we have used a new approach
for the modeling of symmetrical assemblies to predict the ring
structure of the outer membrane secretin EscC21–174 (see Methods)
9.
Even though EscC21–174 was, unlike the inner membrane EscJ, not
captured in an oligomerized state within our crystals, it can be
assumed to adopt a symmetrical ring structure in the assembled
secretin, because nano-gold labeling and EM visualization of the
homologous pIV secretin revealed a symmetrical ring-like arrange-
ment of the pIV N terminus at the periplasmic face of the secretin
oligomer18. It is also not surprising that the isolated EscC21–174
N-terminal fragment does not oligomerize in the absence of the
C-terminal transmembrane region, because this latter domain of the
secretin, as with many outer membrane proteins, has been shown to
drive the oligomerization appropriately within the membrane milieu.
Our molecular modeling is based on the assumption of 12–14 secretin
subunits constituting the symmetrical ring structure. Although the
relative stoichiometry of the different T3SS components (InvG/EscC:
PrgK/EscJ: PrgH/EscD) is controversial in the field, the stoichiometry
of the outer membrane secretin is well established, and 12–14 subunit
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Figure 1 Basal body of the T3SS. (a) Representation of the basal body of
the T3SS and the components that assemble the complex (the basal body
contains only the integral T3SS membrane proteins and lacks the internal
stalk and extending needle of the assembled T3SS needle complex1–7.
InvG/EscC and PrgK/EscJ are the respective orthologs from S. typhimurium
and EPEC2–9. A third prominent component of the basal body has been
best characterized in S. typhimurium (PrgH) and is thought to interact with
the inner membrane (IM) ring PrgK1–11. The coloring corresponds to the
schematic below, showing the domain organization of EscC (InvG), EscJ
(PrgK) and PrgH. (b) Crystal structures of T3SS basal body components
EscC21–174, PrgH170–362 and EscJ21–190 and their proposed position in the
S. typhimurium T3SS EM map, as described here (EMDB 1224 and 1214)
(refs. 5,21). The box in black indicates the approximate dimensions of the
C-terminal protease-resistant ‘secretin homology region’ as determined
by EM reconstructions of the secretin PulD, and the black arrow below
highlights the previously proposed position for the secretin N-terminal
region and the secretin N terminus15,18. The docked models are equivalent
to the models presented in Figures 2 and 4. OM, outer membrane;
TMH, transmembrane helix.
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The injectisome requires more than twenty proteins to assemble, about fifteen of which are 
thought to be part of the functional protein complex. In Yersinia, all T3S genes are located on 
a large virulence plasmid, called pYV in Y. enterocolitica (Figure 1.5). The following chapter 
gives a brief overview of the conserved components of the injectisome, depicted in Figure 
1.6. All of these are essential for the translocation of effectors. The protein names are given 





The extracellular needle is generated by helical polymerization of a small protein (YscF) 
(Cordes et al., 2003; Deane et al., 2006). The needle is terminated by a tip (LcrV, which most 
likely forms a pentamer) (Müller et al., 2005; Broz et al., 2007), which is proposed to act as a 
scaffold for a hydrophobic pore (YopB and YopD) permeating the host membrane 
(Håkansson et al., 1996; Blocker et al., 1999). The length of the needle is regulated by a 
protein (YscP) that has been proposed to act as a molecular ruler, as its size linearly correlates 
with needle length (Journet et al., 2003; Cornelis et al., 2006; Wagner et al., 2009). 
Figure  1.5:  Genetic  map  of  the 
pYVe227  plasmid  of  Y.  entero‐
colitica W22703. 
This  virulence  plasmid  is  closely 
related  to  pYVe40,  which  was  mainly 
used  in  this  study.  The  genes  are 
coloured  according  to  the  part  of  the 
apparatus  they  encode.  Genes  in 
green  encode  the  Ysc  secretion 
machinery  and  its  control;  genes  in 
light  blue  encode  the  translocation 
machinery; genes  in dark blue encode 
the  effector  proteins;  genes  in  red 
encode  chaperones;  genes  in  orange 
are  involved  in  regulation  of  gene 
expression;  the  gene  in  brown 
encodes  an  adhesin;  genes  in  gray 
encode arsenic resistance proteins. 





The basal body contains two membrane-spanning ring structures. The OM ring consists of a 
12-14mer of a protein from the secretin family (YscC) (Koster et al., 1997; Kubori et al., 
1998; Blocker et al., 2001; Spreter et al., 2009). Its polymerization and integration into the 
OM is assisted by a pilotin (YscW) (Koster et al., 1997; Burghout et al., 2004a). The so-
called MS ring in the inner membrane (IM) is formed of 20-24 copies of a lipoprotein (YscJ) 
(Kimbrough and Miller, 2000; Crepin et al., 2005; Yip et al., 2005; Silva-Herzog et al., 
2008), which interacts with a bitopic protein (YscD) (Kimbrough and Miller, 2000) proposed 
to connect the two rings through its periplasmic domain (Spreter et al., 2009). 
 
IM export machinery 
In addition to the MS ring, the IM contains five proteins YscR, S, T, U, and V, which are 
highly conserved essential components of the injectisome. All five proteins span the inner 
membrane with multiple transmembrane helices (Allaoui et al., 1994; Fields et al., 1994; 
Ghosh, 2004; Berger et al., 2010), as has also been shown for their flagellar counterparts, 
FliP, FliQ, FliR, FlhB, and FlhA (Ohnishi et al., 1997; Minamino and Macnab, 2000). Based 
on their topology and localization, and because interactions were observed between these 
proteins, as well as to the MS ring component and the ATPase (Minamino and Macnab, 2000; 
McMurry et al., 2004), YscR, S, T, U, V have been termed “export apparatus” or “IM export 
machinery” (Cornelis, 2006). YscR, S, and T consist mainly of TM helices, whereas YscU 
and YscV both contain a large soluble C-terminal domain (Plano et al., 1991; Allaoui et al., 
1994). 
Despite the great importance that has been attributed to these proteins, very little is known 
about their localization, stoichiometry, or function in the injectisome. Only for YscU, a 
function in the recognition of export substrates could be shown (Sorg et al., 2007). 
All five proteins were proposed to be located within a membrane patch inside the MS ring, 
where they are thought to select substrates and to control the access to the translocation 
channel (Aizawa, 2001; Tampakaki et al., 2004). Taking into account the predicted number of 
transmembrane helices of each protein, the inside diameter of the model of the MS ring 
(6 nm; Yip et al., 2005), and an estimated transmembrane helix average diameter of 1.2 nm 






There are four essential cytosolic components that are thought to be part of the injectisome 
structure: An ATPase (YscN), two adjacent proteins (YscK and YscL), and a homologue of 
the flagellar C ring component (YscQ). All four proteins have been shown to interact 
(Jackson and Plano, 2000). The P. syringae ATPase HrcN is activated upon oligomerization 
and forms hexamers as well as dodecamers (Woestyn et al., 1994; Pozidis et al., 2003; Müller 
et al., 2006). The obvious idea about the function of the ATPase is that is energizes the 
transport. However, the observed substrate export rates (up to a thousand molecules per 
minute) (Schlumberger et al., 2005) would be too high for the low measured ATPase activity 
(Chevance and Hughes, 2008). In addition, in the flagellum it has been shown that export is 
not completely dependent on the ATPase, but on the proton-motive force (PMF) (Minamino 
and Namba, 2008; Paul et al., 2008). The role of the PMF has also been demonstrated for the 
injectisome (Wilharm et al., 2004). Therefore, the main function of the ATPase might rather 
be to detach chaperones and unfold export substrates (Akeda and Galán, 2005). While YscL 
might act as a negative regulator of the ATPase (Blaylock et al., 2006; Pallen et al., 2006), as 
has been shown for its flagellar homologue FliH (Minamino and Macnab, 2000; González-
Pedrajo et al., 2002), the role of YscK and YscQ is unclear. Although the function of the 
flagellar C ring in reversal of the rotation direction (Driks and DeRosier, 1990; Khan et al., 
1992) is obsolete in the injectisome, the homologue of YscQ has been shown to localize to the 
proximal side of the injectisome in Shigella (Morita-Ishihara et al., 2005). 
Figure  1.6:  Schematic  representation  of  the 
Y. enterocolitica  injectisome  (modified  from 
Diepold et al. (2010)) 
The  tip  structure  is  derived  from  Müller  et  al. 
(2005); the global structure of YscC, D, J is based on 
data from Spreter et al. (2009); position and overall 
shape  of  the  IM  proteins  and  the  cytoplasmic 







Regulation of type III secretion is mainly exerted on two levels: formation of the injectisome, 
which is a relatively slow process, and secretion of effectors, which occurs very rapidly once 
it is triggered (Schlumberger et al., 2005). Both steps can be induced separately in vitro, and 
there is strong evidence that they occur discretely in vivo as well. However, the molecular 
signals leading to the events in vivo are only beginning to be characterized.  
Formation of the injectisome is generally induced when the temperature reaches the body 
temperature of the host. In Yersinia and Shigella, expression of the injectisome proteins is 
turned on at 37°C (Skurnik et al., 1984; Michiels et al., 1991; Lambert de Rouvroit et al., 
1992; Hoe and Goguen, 1993; Durand et al., 2000).3 This is achieved through the 
temperature-dependent expression of the main transcription factor VirF, and through the 
dissociation of the chromosomal histone-like protein YmoA, which blocks transcription of the 
injectisome genes at lower temperatures, from the DNA (Michiels et al., 1991; Lambert de 
Rouvroit et al., 1992) (Figure 1.7). 
Once the injectisome is built, it is ready for the export of effectors. However, no undirected 
secretion of effector proteins into the surrounding medium occurs in vivo. Translocation of 
effectors only occurs into host cells, after contact to those cells has been established (Rosqvist 
et al., 1994; Sory et al., 1995). In vitro, secretion into the supernatant can be induced, even in 
the absence of host cells, by chelation of Ca2+ ions (in the case of Yersinia and Pseudomonas) 
or addition of Congo red (in Shigella) (Cornelis, 2006). Whether these conditions mimic host 
cell contact or are artefacts could not be determined so far. Cisz et al. (2008) showed that in 
P. aeruginosa, calcium addition in previously secretion-permissive medium blocked only the 
secretion of effectors, but not of translocators, pointing out that the regulation of secretion is 
more complex than thought previously. Effector translocation in vivo can also be controlled 
by microaerobic conditions in S. flexneri and EHEC (Marteyn et al., 2010; Schüller and 
Phillips, 2010) and by the pH value of the surrounding vacuole in S. enterica SPI-2 (Yu et al., 
2010). These examples show that the translocation of effectors is likely to be controlled 
differently between species, according to the lifestyle of the respective bacterium. 
                                                        
3 In Salmonella, expression of SPI-1 T3S genes seems to be influenced stronger by factors like pH, 
osmolarity and oxygen levels (Ibarra et al., 2010) and has been shown to change over time (Bumann, 
2002), which is conceivably benefitial for the subsequent steps of invasion and intracellular survival. 
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At least five proteins (YopN, SycN, TyeA, YscB, LcrG) are required for the control of 
effector secretion in Yersinia. Deletion of any of these protein leads to a “Ca2+ blind” 
phenotype with effector secretion under normally secretion-non-permissive conditions 
(Yother and Goguen, 1985; Forsberg and Wolf-Watz, 1988). A complex involving at least 
four of these proteins (Ferracci et al., 2005) is thought to act as a “plug” at the cytoplasmic 
side of the injectisome (Figure 1.7). The Shigella YopN homologue MxiC has been shown to 
interact with the ATPase Spa47 (Botteaux et al., 2009), suggesting a pathway through which 
the effect of this plug is exerted. Based on the crystal structure of the Shigella needle subunit 
MxiH and various mutants displaying defects in host sensing, a model has been devised 
where host sensing at the needle tip is transmitted to the secretion apparatus and the plug via 




Beyond these “on-off” type mechanisms, there are further layers of regulation. In Yersinia, it 
has been shown that chelation of calcium ions in the medium at 37°C not only allows 
secretion, but also leads to an increase in the synthesis of effector and translocator proteins 
(Stainier et al., 1998) as well as in the synthesis of machinery proteins (Allaoui et al., 1995b). 
The effect of the extracellular calcium concentration on the production of needles was 
reported to be even more pronounced (Müller et al., 2005). This effect is based on the action 








Figure  1.7:  Simplified  schematic  view  of  type  III  secretion  regulation  in  Yersinia 
enterocolitica (adapted from Müller (2004)) 
At 28°, the histone‐like protein YmoA blocks the promoter regions of the T3S genes (virF, yop and 
ysc).  At  37°,  YmoA  dissociates,  and  VirF,  the main  transcription  factor  of  T3S  gene  expression, 
triggers  transcription  of  the  yop  and  ysc  genes.  However,  transcription  remains  partially 
downregulated by YscM1/M2. Secretion is blocked by the presence of Ca2+ in the medium through 
the  action  of  the  secretion  plug  (pink).  As  soon  as  Ca2+  is  chelated  or  host  cell  contact  is 
established, the secretion plug is released and YscM1/M2 are secreted, along with the effectors, 




downregulate transcription of the T3S genes (Figure 1.7). Once conditions are secretion-
permissive, they are exported, which leads to an increased expression of injectisome 
components and effectors. While it is clear that transcription levels are influenced by the 
extracellular calcium level, the scale of the effect strongly differs between reports (Allaoui et 
al., 1995b; Stainier et al., 1998; Müller et al., 2005). So far, no quantitative comparison of the 
effect of the calcium concentration on different events has been performed. 
Another type of regulation is provided by the feedback inhibition of secretion by effectors, 
once a cell has been infected by a bacterium. Cisz et al. (2008) showed that the presence of 
ExoS, the P. aeruginosa homologue of YopE, in a host cell suppresses translocation of 
effectors into this cell by subsequently attaching bacteria. A similar role could be exerted by 
YopH, an effector highly similar to the negative regulators YscM1/M2 in Y. enterocolitica 
(Stainier et al., 1998). 
The increased availability of reporter constructs and imaging techniques that allow to follow 
the events during infection of host cells are likely to lead to new insights into events during in 








Bacteria harbor a variety of transmembrane protein complexes. They function, among other 
things, in attachment (such as fimbrae and adhesins), movement (flagella), or transport across 
membranes (secretion systems, see Figure 1.2). In general, it is assumed that the 
intermolecular forces that predominate in membrane complexes greatly differ from those 
governing soluble protein complexes (Helms, 2002). Association of membrane proteins can 
be caused by affinity between transmembrane helices (reviewed in Schneider et al. (2007); 
Figure 1.8 A) or by the entropically favorable decrease in lipid order around the proteins in a 
complex (Morrow et al., 1985; Figure 1.8 B). Of course, complex formation of membrane 
proteins can also be caused by motifs outside of the transmembrane helices, as was proposed 




It is a particularity of the two-dimensional space to which proteins in membrane complexes 
are restrained, that the integration of proteins into the complex is very demanding. This 
especially applies to closed membrane rings, as in the injectisome. Proteins enclosed by such 











A:  Illustration  of  the  forces  that  may  lead  to  the  association  of  transmembrane  helices.  1 
represents protein:water, 2 protein:protein, 3 protein:bilayer core and 4 protein:bilayer interface 
interactions. Proteins are shown in blue, lipid molecules in orange and water molecules in red and 
gray. B:  Decrease  in  the  amount  of  ordered  lipids  during  the  assembly  of  a membrane  protein 
complex.  The  lipids  in  the  first  and  second  layers  around  the  proteins  are  assumed  to  be 




At the moment, our understanding of forces that govern the assembly of protein complexes 
within membranes remains limited, mostly due to the lack of defined structures. Purification 
of large transmembrane complexes is notoriously difficult. On one side, the complex has to be 
extracted from the membrane, and in some cases from the peptidoglycan layer, which requires 
destabilization of the bacterial membrane and the use of detergent; on the other side, the 
complex should remain intact and not lose any components, which calls for very gentle 
conditions. The ensuing difficulties are illustrated by the fact that, although 15-30% of all 
ORFs in different species are predicted to encode transmembrane proteins (Kashino, 2003) 
and membrane protein-containing complexes are crucial to maintain cell signaling, 
metabolism and other central functions, comparatively few membrane protein complexes 
have been purified and characterized in detail. The task becomes even more difficult when the 
assembly of a transmembrane complex is examined. In this case, the purification ideally does 
not rely on physicochemical properties of the complex, such as its size (a criterion otherwise 
often used to purify large complexes), as this would likely exclude early intermediates. 
Instead, a component thought to be the nucleation core of the complex or integrated early can 
be fused to an affinity tag. While it involves the alteration of a protein, the advantage of this 
method is that it allows to apply relatively gentle purification procedures that are largely 
independent of the assembly state of the complex. 
In many cases, a tandem-affinity purification (TAP) tag strategy is used for the purification of 
protein complexes. The TAP tag originally consists of the Calmodulin Binding Peptide 
(CBP), a TEV protease cleavage site, and Protein A (Rigaut et al., 1999). In other studies, 
different combinations of affinity tags, like a combination of FLAG and His tag, proved to 
result in higher yields (Yang et al., 2006). The TAP approach has even been used for genome-
wide protein complex screens in yeast (Gavin et al., 2002; Gavin et al., 2006). While 
membrane protein complexes were excluded in the first analysis, they were purified with a 
modified protocol and analyzed in the follow-up study. 340 out of 628 tagged membrane 
proteins could be purified, a ratio similar to the one in soluble proteins. However, the 
overview of all purified complexes shows that protein complexes are still significantly 
underrepresented (Gavin et al., 2006), pointing out the difficulties in copurification. 
A completely different approach to study the assembly of transmembrane complexes is the 
utilization of fluorescent fusion proteins. The main advantage of this approach is the 
possibility to trace assembly in vivo in real time without the need of lengthy, and possibly 
complex-disrupting, purification procedures. A major disadvantage is the need to 
fluorescently label several components to get a high resolution in the order of assembly. 




technique: (i) The labeled protein has to be present in multiple copies within the complex to 
be detectable, (ii) the protein complex needs to have a specific distribution within the cell that 
differs from the distribution of the free component (unless more sophisticated diffusion-based 
methods such as fluorescence correlation or cross-correlation spectroscopy are applied), (iii) 
the used fluorescent tag must not impede the formation of the complex, (iv) the microscope 
must have a sufficient resolution and especially a high sensitivity to visualize and resolve the 
assembled proteins. As most fluorescent proteins have a size of 25-30 kDa (Shaner et al., 
2005), and smaller alternatives, such as tetracysteine tags (Adams et al., 2002; Andresen et 
al., 2004), require additional manipulation (Enninga et al., 2005) and may also disturb the 
function of the protein (own unpublished observations), a test for the formation and/or 
functionality of the protein complex harboring the fusion protein is essential in this approach. 
If all requirements are met, the analysis of fluorescent fusion proteins can yield valuable 
insights into the in vivo assembly of bacterial membrane complexes, as shown by two recent 
studies (Lybarger et al., 2009; Minamino et al., 2009). 
 
1.2.2. Assembly of the bacterial flagellum 
Along with the ribosome, the bacterial flagellum is one of the most complex prokaryotic 
nanomachines. The assembly of this transmembrane complex has been studied for thirty 
years, and has been extensively reviewed (Aizawa, 1996; Aldridge and Hughes, 2002; 
Macnab, 2003; Macnab, 2004; Apel and Surette, 2008; Chevance and Hughes, 2008; 
Minamino et al., 2008). 
A landmark paper in the study of flagellar assembly was published in 1992, when Kubori 
et al. examined the formation of flagellar precursors in a wide array of deletion mutants. They 
found that overall, assembly of the flagellum starts at the IM and proceeds sequentially to 
more distal structures. The first detected structure was the MS ring, which did not require any 
other structural protein than its component FliF. In various deletion strains, different 
precursors of the hook-basal body4 could be visualized, which allowed to establish an 
approximate pathway for flagellar assembly (Kubori et al., 1992). 
Further studies, mainly based on heterologous overexpression of proteins, helped to elaborate 
details of the assembly pathway: Immediately after assembly of the MS ring, the C ring /                                                         
4 Hook-basal bodies (HBB): The secretion machinery of the flagellum, without rotor/stator proteins and the 
extracellular flagellin appendix, expressed by the class 2 operons (see Figure 1.10). 
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switch complex, consisting of FliG, FliM, and FliN, can be formed (Kubori et al., 1997; Lux 
et al., 2000; Macnab, 2003) (Figure 1.9A)5. For the next observable steps, integration of the 
eight proteins FlhA, FlhB, FliH, FliI, FliO, FliP, FliQ, and FliR, proposed to form an export 
apparatus, has to occur. Whether in wild-type conditions, these proteins require the MS ring 
and the C ring for their assembly, could not be determined so far, which leaves the possibility 




5 The flagellar C ring is essential not only for the switching of the rotation direction, but also for the export 
of distal components (Macnab, 2003). However, two recent reports showed that in C ring mutants, the 
export can be partially restored by overexpression of the ATPase (Konishi et al., 2009) or the master 






























Afterwards, the flagellum grows outwards, subsequently forming the rod, the P and L rings in 
the peptidoglycan layer and in the OM, respectively, the hook, and the filament. The 
polymerization of the extracellular components is guided by specific cap proteins (Ikeda et 
al., 1985; Yonekura et al., 2000). An overview of the complete assembly pathway is depicted 
in Figure 1.9B. 
The protein assembly order is, in a simpler way, mirrored in the order of expression of the 
flagellar genes. Genetic studies in E. coli (Komeda, 1986; Kutsukake et al., 1990; Chilcott 
and Hughes, 2000) showed that the 14 flagella operons are arranged in a regulatory cascade of 
three classes: The single class 1 operon flhDC controls expression of the class 2 operons, 
which encode for hook-basal body components (shown red in Figure 1.10) and the 
transcriptional activator for the class 3 operons. Transcription of the class 3 operons does not 
occur before completion of hook-basal bodies and leads to the expression of the rotor/stator 






expression  and  assembly  of  the 
flagellum (Apel and Surette, 2008). 
The  operons  for  the  flagella  systems 
are  expressed  in  a  defined  temporal 
order (left side, top to bottom). Class 2 
and  3  operons  and  proteins  are 
marked  in  red  and  blue,  respectively. 
The  class  3  sigma‐factor  FliA  is 
inhibited by the anti‐sigma factor FlgM 
until  FlgM  is  exported by  a  functional 
T3S system.  
rotates as the monomers of FliC are incorporated into the
filament. The filament grows at the tip, and the cap is guided
along the helical spiral as filament subunits are incorporated
[66].
The flagellar filament is a long helix composed of up to
20,000 FliC subunits [2]. In a comparison of amino acid
sequence between different bacterial species, the surface
domains of the filament are not conserved, but sequence that
mediates filament assembly is highly conserved among different
bacteria [67]. The N and C terminus of FliC have conserved
hydrophobic residues that interact through a coiled coil
interface. The bacterial flagellum can be 15 μm in length with
a diameter of only 120–150 Å [68]. Yonekura et al. [69] have
solved the structure of the flagella filament by cryomicro-
scopy, and have concluded the diameter of the central channel
is only 20 Å. This imposes certain limitations on the assembly
of FliC, and it has been speculated that FliC must be con-
siderably unfolded to pass through the central channel and
assemble at the tip of the filament. Conversely the narrow
channel may serve some function as it would prevent pre-
mature folding of the monomer prior to FliC reaching the tip
of the assembling filament [69]. FliS, a chaperone of FliC,
binds the C-terminal domain of the filament monomer. In vitro
experiments have demonstrated that FliC binds FliS and the
substrate chaperone interaction prevents polymerization of
FliC [70].
6. The stator of the flagellum
Torque generation is driven by a membrane gradient of H+ in
neutrophiles [71,72], and by Na+ in marine Vibrio and alka-
lophiles [73,74]. Mot A and Mot B form the flagellar stator; the
non-rotating component of the flagellar motor. MotA/MotB are
integral membrane proteins [75], and participate in the initial
step of torque generation which is necessary for the rotation of
the completed flagella [76]. Mot mutant of Escherichia coli
produce fully assembled flagella that are incapable of rotation,
and are paralyzed [77]. Blair and Berg [78] designed an expe-
riment in which they induced expression of MotA or MotB from
a plasmid encoding either Mot protein. When tethered mutants
were induced to express the complemented Mot protein, the
cells began to rotate around the point of attachment. Over time
as the Mot protein levels increased the rotation speed increased
in a series of eight sequential steps. From these observations it
was concluded that up to eight torque generating units exist in
the functional stator, and furthermore this structure is composed
of both MotA and MotB [78]. Since these earlier studies, gel
filtration chromatography has demonstrated a MotA4MotB2
stoichiometry of the stator [79]. The mechanisms by which the
stator and motor convert ion gradients into torque are beyond
the scope of this review. We refer the reader to other literature
that should provide several attractive models addressing this
biophysical process [80–83].
Alkaline phosphatase protein fusions demonstrated that the
carboxyl-terminal portion of MotB is located on the periplas-
mic side of the inner membrane [84]. An Asp32 residue of
MotB located near the inner face of the cytoplasmic membrane
is likely involved in proton translocation. This residue forms a
probable proton binding site, however the residue's fun tion
cannot be replaced by another protonatable amino acid [85].
MotA has a much larger cytoplasmic domain than MotB [76].
Mutagenesis of the MotA cytoplasmic residues Arg90 and
Glu98 and the residues at the cytoplasm–membrane spanning
interface, Pro173 and Pro222, were determined to be important
for MotA function [86]. Motility assays demonstrated that
mutations th t r versed the charge of the residue ere more
severe then mutations that neutralized the charge. It is
postulated that these charged residues may facilitate an
electrostatic interaction with the motor protein FliG [86].
7. Regulation of flagella gene expression
Under particular environmental conditions, E. coli synthe-
sizes multiple flagell which facilitate propulsion a d chemo-
taxis. The genes involved in the generation of flagella and
chemotactic machinery form an intricate genetic network that
includes examples of both positive and negative regulation, as
well as regulated feedback loops (Fig. 1). Elegant genetic studies
hav shown that the 14 flagella operons are arranged in
a regulatory cascade of three classes [87–90]. The class 1
operon encodes the transcriptional activator of class 2 operons,
Fig. 1. Temporal order of gene expression and assembly of the flagellar apparatus.
The operons for the flagella systems are expressed in a defined temporal order
arranged in this figure the top to bottom [98]. The Class 2 and 3 operons and
corresponding products are indicated in red and blue, respectively. The inner
membrane (IM), peptidoglycan (PG) and outer membrane (OM) are as labeled. The
anti-sigma factor FlgM inhibits the Class 3 sigma factor FliA until completion of a
function fTTSSwhereupon it gets exported from the cell. FliA also regulates its own
expression [99] and contributes to the expression of other Class 2 operons [94,100].




The assembly of the injectisome has not been studied as intensely as the assembly of the 
flagellum. Transcriptional control of the operons of the injectisome is simpler compared to the 
flagellum. As the virulence T3S systems have only one transcription factor (class 1) and no 
homologues of the proteins encoded in the class 3 operons in the flagellum, all injectisome 
components are encoded in operons corresponding to the flagellar class 2, and transcription is 
expected to occur simultaneously. A more detailed analysis is performed in chapter 4.2. 
Most studies on the assembly of the injectisome were performed in Salmonella SPI-1 
(Yersinia homologues are given in brackets). When the Salmonella MS ring components 
PrgH and PrgK (YscD and YscJ) were overexpressed in E. coli, stable ring structures could 
be observed (Kimbrough and Miller, 2000). This suggested that injectisome assembly is 
initiated at the IM, like it is the case for the flagellum (Kimbrough and Miller, 2002). Next, 
the MS ring would, through an unknown mechanism, assemble with the secretin ring (YscC) 
in the OM, which has been shown in Yersinia to be a stable structure as well, in the presence 
of its pilotin (YscW) (Koster et al., 1997; Burghout et al., 2004a; Burghout et al., 2004b). As 
all further cytosolic and IM components of the injectisome (YscK, L, N, Q, R, S, T, U, V in 
Yersinia) are required for export of the needle subunit, which is the next observable event, 
their assembly order could not be assigned. After needle assembly is finished, the substrate 
specificity of the export machinery is switched (Agrain et al., 2005), and the system is ready 
for effector secretion (Figure 1.11). 
Sukhan et al. (2001) showed that InvG (YscC), PrgH (YscD), and PrgK (YscJ) were required 
to form the “needle base” corresponding to both transmembrane rings. While they could 
purify low amounts of assembled InvG from the membrane in mutants lacking any of the two 
other proteins, PrgH multimers were found in low amounts in the InvG mutant strain, but not 
in a PrgK mutant, and the detection of PrgK multimers required the presence of both other 
membrane-ring forming proteins. Again, the order of the later steps could not be assessed, and 
an assembly pathway similar to the one depicted in Figure 1.11 was proposed. 
An additional study was performed in EPEC (Ogino et al., 2006). As in the other organisms, 
the three proteins forming the transmembrane rings, EscC, D, J (YscC, D, J, respectively) 
were required for assembly of the T3S apparatus. This study further showed by pull-down 
experiments that EscC directly interacts with EscD and the needle subunit EscF, while EscJ 








These studies are further reviewed by Cornelis (2006), and Enninga and Rosenshine (2009). 
The main obstacle in all presented analyses is the low number of distinguishable intermediate 
structures which does not allow to track any event before the formation of the “needle base” 
and between this event and the completion of the needle. An approach based on fluorescently 
labeled proteins, which has the potential to overcome these problems, has not been applied 
















Figure  1.11:  Assembly model  for  the  Salmonella  SPI‐1  injectisome  (Kimbrough  and Miller, 
2002). 
During the sec‐dependent phase, the base components PrgH/PrgK and InvG are exported and self‐
assemble  in  the membranes. At some point during this phase the export apparatus  (depicted  in 
red) becomes associated with the base, making  it competent for secretion of type III‐dependent 
substrates.  The  type  III‐dependent  phase  begins  with  the  secretion  and  assembly  of  needle 
components  (PrgI,  PrgJ).  Following  completion  of  the  needle,  the  specificity  of  the  secretion 
apparatus is switched to secrete translocators and effectors.  
needle subcomponent protrudes from the base structure,
appearing to start from the top of the InvG outer membrane
ring (Fig. 2). However, assembly of the needle substructure
probably begi s within the base, starting at the level of the
PrgH/K inner membrane rings. This conclusion is based
upon images of NCs, which have had their outer rings
removed by mechanical disruption, showing the inner rings
attached directly to a rod shaped structure which is contigu-
ous with the needle (Fig. 3, unpublished). This is further
supported by studies by Anan et al. showing that in the
absence of the outer-ring protein InvG, the major needle
protein PrgI is still associated with the base of the complex
[14]. The n edle substructure is able to extend beyond the
base by polymerizing through the center of the outer
membrane secretin complex, InvG, in a manner which may
be mechanistically similar to the polymerization of type IV
fimbria across the outer membrane through its associated
secretin [27].
Deletional analysis of SPI-1 genes has shown that once
the basal body of the NC and type III export machinery have
been assembled, only four other proteins are required to
assemble the needle itself. Deletion of the genes encoding
PrgI, PrgJ, InvI or OrgA results in the formation of NC that
are missing the needle (Figs. 3 and 4) [8,14]. Strains that are
deleted for any one of these genes are unable to secrete
additional TTSS substrates indicating that secretion and
assembly of the needle must occur prior to secretion of other
more distal components such as the translocon components
SspB,C, and D. The role of InvI and OrgA in assembly of
the needle is unknown. Although they do not share sequence
similarity with any of the conserved type III export compo-
nents, they may have a specific role in export and assembly
of the dle.
PrgI is the major structural component of the needle [9].
It is a small (8.7 kDa), basic protein predicted to form
coiled-coils, a common feature among proteins that form
filamentous structures such as flagella. Interestingly, PrgI
and its family members are associated only with TTSS of
animal pathogenic bacteria. Secretion of PrgI is type III-
dependent, requiring a fully functional secretion apparatus.
In the absence of a functional apparatus, PrgI protein levels
become almost undetectable, implying th existence of a
regulatory mechanism that prevents accumulation of needle
subunits within the bacterial cytoplasm [8].
PrgJ is required for PrgI secretion and formation of the
needle substructure, suggesting that it plays a role in
polymerization of PrgI into the needle. Like PrgI, PrgJ is
also type III-secreted and co-purifies with the NC. Based
upon these findings we have proposed that PrgJ is a minor
component of the needle itself [8]. PrgJ and its family
members are all small proteins (11 kDa) which are always
encoded directly upstream of the highly conserved PrgK
family. While members of the PrgJ family share very
limited primary sequence homology among themselves,
each of them has significant sequence similarity to their
respective PrgI family member.
It has been proposed that PrgI and PrgJ are analogous to
the flagellar hook assembly proteins FlgE and FlgD [13].
Fig. 4. Morphological pathway of needle complex assembly. During the sec-dependent phase, the base components PrgH/PrgK and InvG are exported and
self assemble in the membrane. At some point during this phase the export apparatus (depicted in red) becomes associated with the base making it competent
for secretion of type III-dependent substrates. The type III-dependent phase begins with the secretion and assembly of needle components (PrgI, PrgJ).
Following completion of the needle, secretion of InvJ switches the specificity of the secretion apparatus to secrete translocon components (SspBCD) and
effectors.




























The formation of the type III secretion injectisome involves the assembly of about fifteen 
different, mostly multimeric proteins into a structure spanning both bacterial membranes. This 
assembly is likely to occur in an ordered fashion, but due to the lack of observable 
intermediate structures, little is known about the sequence of events. Our aim was to shed 
light on this process by using a novel approach. Through the creation of functional fluorescent 
fusion proteins that cover the major subcomplexes of the injectisome, and the analysis of their 
localization in strains lacking other type III secretion components, we sought to determine the 
requirements for the assembly of the respective proteins. 
In combination with co-immunoprecipitation experiments, this approach permits to determine 
the assembly order and kinetics of the Yersinia injectisome in much more detail than previous 
studies. Further, it is not restricted to the components of the needle complex, but also allows, 
for the first time, the observation of dynamic properties of the cytosolic components of the 




















The following chapter is an excerpt from the manuscript “Deciphering the assembly of the 
Yersinia type III secretion injectisome”, published in April 2010 in The EMBO Journal 
29(11), pp. 1928-1940, that has been adapted in style and figure numeration for inclusion in 
this thesis. It contains the abstract, results, supplementary information, and discussion from 
the manuscript, and is followed by an additional “extended discussion” chapter including new 
data that we generated or were published by other groups after the submission of this 
manuscript. 
Material and methods used in the manuscript are included in the corresponding chapter 
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strains and plasmids (strains and plasmids labeled pAD...), performing experiments, analyzing 
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(especially in fluorescence microscopy and immunofluorescence). 
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The assembly of the Yersinia enterocolitica type III secretion injectisome was 
investigated by grafting fluorescent proteins onto several components, YscC (outer-
membrane (OM) ring), YscD (forms the inner-membrane (IM) ring together with YscJ), 
YscN (ATPase), and YscQ (putative C ring). The recombinant injectisomes were 
functional and appeared as fluorescent spots at the cell periphery. Epistasis experiments 
with the hybrid alleles in an array of injectisome mutants revealed a novel outside-in 
assembly order: whereas YscC formed spots in the absence of any other structural 
protein, formation of YscD foci required YscC, but not YscJ. We therefore propose that 
the assembly starts with YscC and proceeds through the connector YscD to YscJ, which 
was further corroborated by co-immunoprecipitation experiments. Completion of the 
membrane rings allowed the subsequent assembly of cytosolic components. YscN and 
YscQ attached synchronously, requiring each other, the interacting proteins YscK and 
YscL, but no further injectisome component for their assembly. These results show that 
assembly is initiated by the formation of the OM ring and progresses inwards to the IM 




3.2. Various substructures of the Yersinia  injectisome  including 
the  C  ring  can  be  monitored  using  functional  fluorescent 
fusion proteins 
To visualize the injectisome and its subunits, the wild-type alleles of yscC, yscD, and yscQ on 
the virulence plasmid of Y. enterocolitica MRS40 were replaced by hybrid genes encoding the 
fluorescent proteins YscC–mCherry, EGFP–YscD, and EGFP–YscQ. Further, a non-polar 
complete deletion of yscN was constructed and complemented in trans with a plasmid 
encoding EGFP–YscN. The fusion proteins were expressed at near wild-type levels; no 
proteolytic release of the fluorophore was detected (Supplementary Figure 1)6. 
To test the functionality of the fusion proteins, the pattern of proteins secreted into the 
supernatant in secretion-permissive medium (BHI-Ox) was analyzed 3 h after induction of the 
system. YscC–mCherry, EGFP–YscN, and EGFP–YscQ were fully functional, whereas the 
strain expressing EGFP–YscD secreted a lower amount of effector proteins (Figure 3.1 B). 
All fusion proteins allowed the formation of needles, which could be visualized by 
transmission electron microscopy (data not shown). 
The localization of the hybrid proteins was analyzed by fluorescence microscopy. Three hours 
after induction of synthesis of the injectisome, fluorescent spots were observed at the cell 
periphery for all labeled proteins (Figure 3.1 A). The formation of these spots was 
independent of the Ca2+ concentration in the medium, showing that their appearance was not 
directly linked to the secretion of Yop proteins by the T3S system (Figure 3.1 A). 
To ascertain that the membrane spots correspond to assembled basal bodies, we constructed a 
strain expressing both YscC–mCherry and EGFP–YscQ, and monitored the localization of the 
green fluorescence from EGFP–YscQ and the red fluorescence from YscC–mCherry. As 
visible in Figure 3.1 C, the green and red spots largely colocalized, with small deviations 
because of chromatic aberrations of the microscope. We thus assumed that the fluorescent 
spots correspond to assembled basal bodies. In a minority of cells, a polarily localized YscC–
mCherry spot without EGFP–YscQ equivalent could be observed in addition to the 
colocalizing spots. We assumed that these polar spots consist of misassembled YscC–
mCherry proteins. Colocalization of spots was also observed for EGFP–YscD and EGFP–
YscN with YscC–mCherry (data not shown). To test for colocalization of the needle with the  
                                                        





























(A)  Fluorescence  deconvolution  microscopy  showing  the  formation  of  fluorescent  spots  at  the 
bacterial membrane of Y. enterocolitica bacteria grown in secretion‐non‐permissive (BHI+Ca2+) and 
secretion‐permissive medium  (BHI‐Ox):  1—MRS40  [wild  type],  2—MA4005  [YscC–mCherry],  3—
AD4050  [EGFP–YscD],  4—AD4136(pAD182)  [ΔYscN+pBAD–egfp–yscN],  5—AD4016  [EGFP–YscQ]. 
All  fusion  proteins  except  for  EGFP–YscN  are  encoded  under  their  native  promoter  on  the  pYV 
virulence  plasmid.  Upper  lane:  mCherry  fluorescence  for  strain  2,  EGFP  fluorescence  for  other 
strains; lower lane: corresponding DIC picture. All fluorescence pictures were taken 3 h after the 
induction of the T3S system by temperature shift to 37°C. Scale bars: 2 μm. (B) Analysis of the Yop 
proteins  secreted  in  secretion‐permissive  conditions.  The  tagged  strains  are  fully  functional  for 
effector  secretion,  except  for  the  strain  expressing  EGFP–YscD  (lane  3),  which  shows  reduced 
secretion.  Culture  supernatants  were  separated  on  a  12%  SDS–PAGE  gel  and  stained  with 
Coomassie Brilliant Blue. Strains as  listed  in  (A), 6—MAAD4006 [EGFP–YscQ, YscC–mCherry], 7—
AD4051 [ΔYscD, negative control]. Bottom line: Needle formation (+/−) in the tested strains (data 






basal body components, bacteria producing EGFP–YscQ were analyzed by 
immunofluorescence with purified antibodies directed against the needle subunit. Overlays of 
the resulting pictures with the EGFP–YscQ fluorescence revealed that the majority of spots 
for YscF and YscQ colocalized (Supplementary Figure 2). A fraction of YscQ spots did not 
correspond to YscF spots. Most likely, the needles of these basal bodies were detached during 
the immunofluorescence procedure. We conclude from all these experiments that the 
fluorescent spots correspond to functional injectisomes. 
 
3.3. Assembly of the injectisome starts from the secretin ring in 
the OM and proceeds  inwards  through  stepwise assembly 
of YscD and YscJ 
As earlier work has shown that secretins can insert in the OM provided they are assisted by 
their pilotin (Burghout et al., 2004a; Guilvout et al., 2006), the fluorescent YscC–mCherry 
and its pilotin YscW were expressed in trans in Y. enterocolitica MRS40(pMA8)(pRS6), in 
the absence of the pYV virulence plasmid encoding the T3S components. YscC–mCherry 
localized in membrane spots (Figure 3.2 A), as observed before for PulD, the secretin 
involved in a type II secretion pathway (Buddelmeijer et al., 2009). These data thus confirm 
earlier results showing that YscC only requires its pilotin for assembly in the OM (Burghout 
et al., 2004a). In the absence of YscW, the majority of YscC–mCherry clustered in spots at 
the bacterial pole (Supplementary Figure 3). This phenotype was clearly distinguishable from 
the membrane spot formation in the presence of YscW, and confirmed the function of YscW 
in proper localization and oligomerization of YscC (Burghout et al., 2004a). 
Not surprisingly, mutants lacking any of the structural ring proteins YscC, YscD, or YscJ 
failed to assemble the cytosolic injectisome components YscN and YscQ (Table II), showing 
that establishment of the membrane-spanning structure formed by YscC, YscD, and YscJ is at 
the beginning of injectisome formation. To test for the assembly order of these proteins, we 
combined the egfp–yscD allele on the pYV plasmid with non-polar deletions in yscC and 
yscJ. While the absence of YscC clearly abolished the formation of EGFP–YscD spots at the 
bacterial membrane, the absence of YscJ did not affect this assembly (Figure 3.2 B). This 





To confirm this order of assembly, we performed co-immunoprecipitation assays using strains 
in which the wild-type alleles of yscD or yscJ on the virulence plasmid were replaced by his-





















YscC,  but  not  of  YscJ.  Copurification  of  the  three  structural  ring  proteins  suggests  the 
stepwise assembly order YscC–YscD–YscJ. 
(A)  Fluorescence  microscopy  showing  the  formation  of  secretin  spots  [YscC–mCherry]  at  the 
bacterial  membrane  in  a  strain  lacking  the  virulence  plasmid  pYV,  after  in  trans  expression  of 
YscC–mCherry and YscW (plasmids pMA8, pRS6) for 3 h at 37°C. Scale bars: 2 μm. (B) Fluorescence 
microscopy  showing  the  formation  of  YscD  spots  at  the  bacterial membrane  in  strains  AD4050 
[EGFP–YscD],  MAAD4018  [EGFP–YscD,  ΔYscC],  and  AD4080  [EGFP–YscD,  ΔYscJ].  YscD  remains 
cytosolic in the absence of YscC, whereas it assembles in membrane spots in the absence of YscJ. 




anti‐YscC,  ‐YscD,  or  ‐YscJ  antibodies.  All  strains  were  ΔYadA  to  facilitate  cell  lysis:  1—LJM4029 
[WT], 2—AD4054  [YscJ‐FLAG‐His], 3—AD4109  [YscJ‐FLAG‐His, ΔYscC], 4—AD4110  [YscJ‐FLAG‐His, 
ΔYscD], 5—AD4112 [YscJ‐FLAG‐His, ΔYscQ]. (D) Analysis of the copurification of YscC and YscJ after 
affinity  purification  of  YscD. Whereas  deletion  of  YscC  abolishes  copurification  of  YscJ with His‐
FLAG‐YscD, YscJ is not required for the interaction between YscC and YscD. Samples were obtained 





effector secretion (data not shown) and hence assumed to assemble in the same way as wild 
type. They were further combined with non-polar deletions in yscC, yscD, or yscJ. In each of 
the strains, the adhesin YadA was removed to facilitate cell lysis. Synthesis of the injectisome 
in these strains was induced under secretion-non-permissive conditions. Mild crosslinking 
was performed, spheroplasts were created, and the bacteria were lysed by the addition of 
detergent (see Material and methods). Afterwards, a one-step affinity purification was 
performed, and the (co-)purification of YscC, YscD, and YscJ was tested. YscJ-FLAG-His 
copurified YscC and YscD from complete injectisomes, and removal of YscQ, a protein 
thought to act further downstream in the assembly process, did not affect this copurification. 
In contrast, removal of YscC prevented copurification of YscD with YscJ-FLAG-His, and 
removal of YscD prevented copurification of YscC (Figure 3.2 C). Likewise, His-FLAG-
YscD copurified YscC and YscJ from complete injectisomes. However, although removal of 
YscC prevented copurification of YscJ with His-FLAG-YscD, removal of YscJ still allowed 
the copurification of YscC (Figure 3.2 D). The amount of purified His-FLAG-YscD was 
reduced in the absence of YscC, most likely as a consequence of decreased cellular YscD 
levels, either because of its mislocalization in the absence of YscC or because of a lower 
expression level. Taken together, these data indicate (i) that the insertion of the secretin ring 
in the OM is required for the subsequent association of YscD and YscJ and (ii) that YscD 
makes the link between YscC and YscJ. Hence, the OM ring is the first ring of the 
injectisome to be assembled. This assembly step is followed by the attachment of YscD, 




To determine at which stage the C ring forms during the assembly process, we combined the 
egfp–yscQ allele with an array of deletions in most injectisome genes (Table II; chapter 7.3 
for details of strains). Deletion of any of the membrane ring proteins (YscC, YscD, or YscJ) 
completely abolished the formation of membrane spots and led to an increased diffuse 
cytoplasmic fluorescence (Figure 3.3). This indicates that the C ring forms after the YscCDJ 
ring structure. Removal of the ATPase YscN or any of its two interacting proteins YscK and 
YscL (Jackson and Plano, 2000; Blaylock et al., 2006) also fully prevented C ring formation 
(Figure 3.3), indicating that assembly of the C ring additionally requires YscN as well as 





Removal of individual proteins YscR, S, T, U, or V from the export apparatus as well as a 
complete deletion of all these proteins did not completely abolish the formation of the C ring. 
However, in the absence of YscR, YscS, or YscV, the number of spots was reduced, 
indicating that these proteins are either beneficial (but not absolutely required) for C ring 
formation, or have a stabilizing effect on fully assembled injectisomes. 
As expected from the fact that YscF, YscI, YscO, YscX, and YopN are substrate proteins 
exported by the injectisome itself, their absence also did not prevent the formation of the C 
ring. Likewise, deletion of LcrG, a regulatory protein (Nilles et al., 1997; Torruellas et al., 






























strains and the strains with deletions  in  the proteins  required  for C  ring  formation—upper  lane: 






3.5. ATPase  assembly  not  only  requires  the  presence  of  the 
YscCDJ platform, but also needs YscK, YscL, and YscQ 
Finally, assembly of the ATPase YscN was tested. As replacement of the wild-type allele on 
the virulence plasmid by a gene encoding a fluorescent fusion protein decreased the 
expression of downstream genes in the virB operon, whereas a complete deletion of yscN was 
non-polar (Figure 3.1 B), egfp–yscN was cloned in a pBAD vector and used to complement in 
trans double deletions in yscN and several other genes. Induction of synthesis of EGFP–YscN 
with 0.05% arabinose led to YscN protein levels similar to the native level (Supplementary 
Figure 1), and to effector secretion at wild-type levels (data not shown). As shown in Figure 
4, YscN assembly required the presence of YscC (secretin), YscJ (MS ring), YscK and YscL 
(two proteins known to interact with the ATPase), and YscQ (the C ring). In contrast, even 
the complete deletion of the IM export proteins YscR, S, T, U, V still allowed formation of 



























with  deletions  of  different  genes.  Wild‐type  protein  levels  were  established  by  EGFP–YscN 





These data suggest that the cytosolic components of the injectisome form a single large 
ATPase–C ring complex, requiring all of its components YscK, L, N, Q to assemble. 
In agreement with the essential function of YscQ for the ATPase assembly, we did not 
observe any needle formation in strains that lack YscQ, but overexpress YscN, in contrast to 




To determine whether assembly of the C ring requires YscN for its ATPase activity or as a 
structural component, a deletion of yscN in an egfp–yscQ background was examined. As 
expected, the resulting strain secreted neither Yops nor the ruler and needle subunits. 
Secretion could be complemented in trans by a wild-type yscN allele, but not by an yscN 
allele encoding YscNK175E altered in the Walker box (Figure 3.5 B, C). 
 
 




formation  of  C  ring  spots  in  AD4104 
[EGFP–YscQ, ΔYscN],  complemented with 
plasmids  encoding wild‐type  YscN  or  the 
catalytically  inactive  YscN(K175E),  3  h 




catalytically  inactive  YscN.  Expression  of 
YscN  was  either  not  induced  (−)  or 
induced with 0.05% arabinose (+). Culture 
supernatants  were  separated  on  a  12% 
SDS–PAGE  gel  and  stained  with 
Coomassie  Brilliant  Blue.  Lower  part: 
Expression  of  YscN  in  the  corresponding 
strains.  Cell  pellets  were  separated  on  a 
12%  SDS–PAGE    gel  and  analyzed  by 
immunoblot  with  anti‐YscN  antibodies. 
(C)  Export  of  different  classes  of 
substrates  in  strains  expressing  EGFP–







Interestingly, however, although YscNK175E was not functional, it did restore the formation of 
the C ring spots (Figure 3.5 A), implying that the YscN requirement for the formation of the 
ATPase–C ring complex is exclusively structural. 
 
3.7. After  assembly  of  the  ATPase–C  ring  complex,  needle 
formation and effector secretion take place rapidly 
The kinetics of C ring formation in a strain expressing EGFP–YscQ was followed in a time-
course experiment. Pictures were taken every 20 min up to 2 h after induction of the ysc-yop 
regulon (Cornelis et al., 1989) in a Ca2+-depleted medium. Weak diffuse cytoplasmic 
fluorescence could be observed 20 and 40 min after the temperature shift, suggesting that 




































Yersinia cytosol (Figure 3.6 A). The rapid synthesis of YscQ was also confirmed by 
immunoblotting (data not shown). The first membrane spots could, however, only be 
observed 60 min after induction. Although the fluorescence intensity of single spots seemed 
to increase over time, the number of spots stayed roughly constant up to 3 h after induction 
(Figure 3.6 A). Interestingly, the timeframe of appearance of the C ring was approximately 
the same as the timeframe of appearance of the needles (Figure 3.6 B) and secretion of the 
effector proteins (Figure 3.6 C), suggesting that needle formation and effector secretion occur 
within a short time after establishment of the ATPase–C ring complex. A model of 






















Next,  YscD  attaches  to  YscC,  which  allows  the  subsequent  completion  of  the  MS  ring  by 
attachment  of  YscJ.  After  the  formation  of  the  membrane  ring  structures,  the  ATPase–C  ring 
complex, consisting of YscN, K, L, and Q assembles at the cytoplasmic side of the injectisome. The 
exact time point of the integration of the IM proteins YscR, S, T, U, and V is unclear. Afterwards, 







The assembly of the T3S injectisome is a complex process that engages >20 different 
proteins, and results in the formation of a nanomachine spanning both bacterial membranes 
and protruding outside the bacterium. So far, little is known about this process. On the basis 
of the observation that heterologously overexpressed S. enterica MS ring components PrgH 
and PrgK form large rings in the absence of any other T3S component, a model was proposed 
(Kimbrough and Miller, 2002) in which the IM ring assembles first, and then fuses with the 
secretin ring in the OM. This model suggests the same general assembly scheme as the one 
that has been proposed for the flagellum (Kubori et al., 1997; Macnab, 2003), but does not 
explain how the two membrane rings find each other. The subsequent steps of assembly could 
not be examined so far. 
To gain better insight into the assembly process and the functional relations between the 
proteins, we constructed strains in which a number of injectisome constituents were fused to 
fluorescent proteins. To minimize artefacts because of non-native expression levels or timing 
of the fusion proteins, we replaced the wild-type allele on the pYV virulence plasmid by the 
hybrid allele in the case of yscC, yscD, and yscQ. The hybrid yscN was plasmid borne, but it 
was expressed at wild-type level. 
All recombinant injectisomes were functional, and in all cases, fluorescent spots appeared at 
the bacterial membrane, distributed all over the bacterial body. Colocalization of the 
fluorophores confirmed that the fluorescent spots correspond to injectisomes. The brightness 
of the spots likely results from the multimeric nature of the tagged proteins, although at this 
stage, one cannot conclude that each spot corresponds to only one injectisome. A fluorescence 
quantification based on external standards, presently in progress, will address this question. 
We observed that the membrane ring-forming proteins YscC, YscD, and YscJ are required for 
assembly of any cytosolic structure. Importantly, by monitoring the formation of YscC–
mCherry and EGFP–YscD spots, we observed that YscC assembles independently of YscD 
and YscJ and that YscD assembles independently of YscJ, but not of YscC. Co-
immunoprecipitation assays confirmed that YscJ requires YscD to become attached to YscC. 
All this implies that the assembly of the injectisome is initiated by formation of the secretin 
ring in the OM and proceeds inwards through stepwise assembly of YscD and YscJ. These 




and YscJ, can form a ring alone (Kimbrough and Miller, 2000). The discrepancy might result 
from the fact that the earlier study was based on heterologously overexpressed proteins, 
whereas this study is based on functional proteins produced in their natural environment at 
native expression levels. These data are also at odd with the report indicating that MxiD and 
MxiJ, the Shigella homologues of YscC and YscJ, interact even in the absence of the 
connector (Schuch and Maurelli, 2001). However, this interaction was observed in the 
absence of the pilot protein. In this case, the majority of secretin proteins are mislocalized to 
the IM (Koster et al., 1997), which might lead to non-native interaction with MxiJ. 
Interestingly, it was shown recently that the assembly of two ring-forming IM components of 
the Vibrio cholerae type II secretion complex also depends on the presence of the OM 
secretin (Lybarger et al., 2009), suggesting conservation or convergent evolution of the 
formation process in these two prokaryotic export systems. Taken together, our results show 
that the order of assembly of the OM and IM rings differs between the injectisome and the 
flagellum. We do not see any obvious reason for this, but this observation indicates that the 
two nanomachines differ more than is often thought. The flagellum is indeed significantly 
more complex than the injectisome because it rotates, which implies not only a motor but also 
bushings in the peptidoglycan and the OM. The P and L rings, having this function, are 
precisely replaced by a very stable secretin ring in the injectisome. This basic structural 
difference might explain the different order of assembly of the two nanomachines. 
The outside-in assembly order consistently shown by co-immunoprecipitation and 
fluorescence microscopy further implies that YscD is the connector between the two 
membrane rings, which is coherent with recent crystal structure and modeling data (Spreter et 
al., 2009). Our biochemical data allow to assess the recent models to integrate the crystal 
structures of the membrane ring proteins into the overall shape generated by electron 
microscopy averaging of purified injectisomes (Hodgkinson et al., 2009; Spreter et al., 2009). 
The electron density between the membranes would be generated by YscD. This in turn 
places YscJ in the IM, as proposed by manual fits (Moraes et al., 2008; Hodgkinson et al., 
2009; Spreter et al., 2009), but not by the best automated fit (Hodgkinson et al., 2009). 
After assembly of the OM and IM membrane rings, cytosolic components can assemble onto 
the structure. The observation that the proposed C ring component YscQ assembles in 
membrane spots colocalizing with the other components shows that the C ring is an integral 
component of the injectisome, confirming an assumption so far mainly based on 




large cytosolic complex consisting of the ATPase YscN, the two interacting proteins YscK 
and YscL, and the C ring component YscQ is formed, requiring all of its components, but not 
the ATPase activity of YscN for assembly. This differs again from the situation in the 
flagellum. There, FliM, FliN, and FliG (together forming the C ring) appear in significant 
amount in the membrane fraction in the presence of FliF (MS ring), but in the absence of FliI 
(ATPase) or FliH (homologue to YscL). This suggests that the flagellar C ring forms in the 
absence of the ATPase complex (Kubori et al., 1997), in agreement with the observation that 
it forms on overexpression of FliM, FliN, and FliG together with FliF (Lux et al., 2000; 
Young et al., 2003). Although the heterologous overexpression of the proteins in these studies 
might account for the different observations, these results can also be the consequence of 
functional differences between the two nanomachines. As the constraint of rotation and 
spatial separation of the C ring and ATPase does not exist for the injectisome, the apparatus 
could be optimized for secretion. A tighter contact between the ATPase complex and the C 
ring might be a consequence of this optimization. The fact that we could not overcome the 
requirement of YscQ for secretion by overexpression of the ATPase is consistent with the 
essential function of YscQ for assembly of the complete ATPase–C ring complex. 
Our results are also in perfect agreement with earlier results showing interactions between 
YscK, YscL, YscN, and YscQ (Jackson and Plano, 2000). However, the hypothesis that YscQ 
recruits the ATPase should be revised: YscK, L, N, and Q would rather assemble in one step. 
The proposed function of YscL as a negative regulator of ATPase activity (Blaylock et al., 
2006) as well as its direct interaction with YscN and YscQ (Jackson and Plano, 2000) is 
consistent with the presence of YscL in this complex. Less is known about the function of 
YscK. As it interacts with YscQ, but not with YscN and weakly at the most with YscL 
(Jackson and Plano, 2000; Blaylock et al., 2006), it might act at the interface of the ATPase–
C ring complex. 
Formation and assembly of the ATPase–C ring complex did not depend on any of the five 
proteins forming the export apparatus, even though the number of membrane spots was 
reduced when YscR, YscS, YscV, or the five proteins YscRSTUV were missing. This implies 
that a YscKLNQ complex docks onto the IM ring rather than onto the export apparatus, which 
agrees with the observations made with the flagellum (Kubori et al., 1997). As currently, little 
is known about stoichiometry, localization, and function of the export apparatus, its function 
in the assembly process remains unclear. 
Regulation and assembly of the type III secretion system of Yersinia enterocolitica 
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In conclusion, this work shows that the assembly of the injectisome starts with the formation 
of the stable secretin ring in the OM, and proceeds inwards through discrete attachment steps 
of YscD and YscJ at the IM. Afterwards, the components of the cytosolic ATPase–C ring 
complex assemble at the cytosolic side of the injectisome in one step, which allows the 
























YscC‐mCherry:  MA4005;  EGFP‐YscD:  AD4050;  EGFP‐YscN  (ΔYscN  +  pBAD‐egfp‐yscN): 
AD4136(pAD182);  EGFP‐YscQ:  AD4016;  EGFP  (pBAD‐egfp):  MRS40(pISO101).  All  fusion  proteins 
except for EGFP‐YscN are encoded under their native promoter on the pYV virulence plasmid (see 
Material and Methods for details). 




































B:  Fluorescence  deconvolution microscopy  showing  the  co‐localization  of  EGFP‐YscQ with  YscF, 
visualized by immunofluorescence, in AD4016 bacteria. Sharpness and intensity of the EGFP‐YscQ 
foci are decreased due to the immunofluorescence treatment. 





































In a manuscript published after the submission of the preceding study, Schraidt et al. (2010) 
describe the topology and organization of Salmonella SPI-1 needle complex components. 
Interestingly, they present electron micrographs of needle complexes that have been purified 
from strain SB1171, which is mutated in the secretin InvG. The presence of NCs is surprising, 
and at odds with our results for the assembly of the Yersinia injectisome as well as with 
previously published results for the same strain. SB1171 carries a 500 bp frame-shift deletion 
after amino acid 84 of invG (Kaniga et al., 1994), and had been shown by Sukhan et al. 
(2001) to be defective for NC base formation and needle formation. Low amounts of PrgH 
(YscD), but no PrgK (YscJ) could be purified from this strain in NC preparations (Sukhan et 
al., 2001). While no obvious changes in the NC purification protocol were given that would 
explain the differences to the observations of Sukhan et al., Schraidt et al. increased the 
culture volume for SB1171 to 18 L (as compared to 2 L for all other strains) to obtain needle 
complexes.  
In Yersinia, absolutely no export of needle subunits was detected in strains lacking the 
secretin (own unpublished data), in agreement with the observation that the assembly of the 
MS ring and the interaction of its components YscD and YscJ categorically require YscC 
(Figure 3.2). Likewise, in Shigella, no interaction between the MS ring components MxiG 
and MxiJ could be observed in the absence of the secretin MxiD (S. Lea, personal 
communication). There are two possible explanations for the different behavior of the MS 
ring subcomplexes in Salmonella SB1171. On one side, it would be possible that assembly of 
the MS ring and subsequent needle formation are assisted by the truncated InvG that is still 
expressed in this strain. This would agree with the observations that (i) the remaining 
N terminus of InvG contains the domain that interacts with PrgH (Spreter et al., 2009; 
Schraidt et al., 2010), and (ii) only the N-terminal secretin part is required for type III 
secretion, as Burghout et al. (2004a) showed that deletions at the C terminus of YscC7 did not 
abolish its function. This hypothesis could be tested by the analysis of needle formation in 
complete deletions of invG in Salmonella or in strains only expressing the equivalent domain 
of YscC in Yersinia. 
                                                        
7 The C-terminal truncations studied in this manuscript were significantly smaller (up to 100 amino acids) 
than the proposed deletion described for strain SB1171. 
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On the other side, in all proposed assembly models, including the one presented in our study, 
the sequence of events is dictated by protein affinities rather than by functional requirements8, 
especially as all proteins are present at the same time (see chapter 4.2). Interestingly, precisely 
YscD, the connector between the ring subunits, is only weakly conserved within T3S systems. 
The resulting different affinities between the ring-forming proteins in different systems could 
cause that in Salmonella, the secretin might not be absolutely required for formation of the 
somewhat stable PrgH/K MS ring. Along these lines, ring structures could be observed in the 
absence of secretins upon heterologous overexpression of PrgH and PrgK (Kimbrough and 
Miller, 2000), and the secretin ring could be mechanically removed from Salmonella NCs 
(Kimbrough and Miller, 2002), leaving structures that were similar to the ones observed for 
strain SB1171. In contrast, in Yersinia (and probably Shigella), the secretin is mandatory for 
the interaction between the MS ring proteins, as has been shown in our study, leading to a 
strict outside-in assembly order. 
 
                                                        
8 The outside-in assembly order proposed in our study additionally involves a penetration of the 
peptidoglycan layer in the first assembly step, by the formation of the secretin ring, which could facilitate 
the attachment of subsequent components. Intriguingly,  the Salmonella SPI-1 system encodes for the lytic 
transglycolase IagB (Miras et al., 1995) that circumvents this problem, whereas the Yersinia Ysc system is 




















Because there was conflicting evidence in the literature, we systematically followed the 
expression levels of the components of the injectisome, as well as needle formation and 
effector secretion, over time and under different conditions. 
On the level of protein expression and stability, we did not detect differential regulation, as all 
proteins were expressed at the same time and reacted similarly to external stimuli. 
However, we discovered that after transient activation of effector secretion, the bacteria were 
able to efficiently shut down type III secretion upon changes in the surrounding medium. 
Interestingly, cessation of needle formation and of effector secretion were controlled by 
different pathways in this case, as the two events were influenced differently by external cues. 
While these novel regulation mechanisms were not yet studied in further detail, they indicate 
that activation and deactivation of the injectisome are controlled events in vivo, which allows 
the bacteria to modulate their response according to the specific requirements.  
 
4.1.2. Kinetics and dynamics of the Yersinia type III secretion system 
Beyond the determination of the assembly order of the injectisome, the functional fluorescent 
injectisome components were used to measure the kinetics of the assembly and the dynamics 
of the cytosolic subunits. 
We could show that formation of the injectisome, in contrast to its function in effector 
translocation, is a slow process. With a combination of microscopy time courses and pre-
induction experiments, we determined that attachment of YscD to the secretin ring, possibly 
in combination with YscC translocation to the OM, is the rate-limiting step in injectisome 
assembly, while all subsequent steps occur within short time. 
Moreover, we demonstrated by photobleaching that the C ring is unlikely to be involved in 
substrate shuttling, but its subunits can be exchanged within minutes, suggesting a rather 





The purification of subcomplexes of the Yersinia injectisome required substantial changes of 
the protocol used in other organisms. The conditions for crosslinking, spheroplast generation 
and cell lysis were optimized, and the adhesin YadA was removed from all strains. 
Co-immunoprecipitation of affinity-tagged injectisome components demonstrated that the 
membrane ring-forming proteins stably interact with each other. Both the needle subunit YscF 
and the inner membrane export machinery component YscV could be detected in the purified 
fractions in substoichiometric amounts. In contrast, the interactions between the membrane 
rings and the cytosolic components seem to be too weak to be detected by this approach, as 
has also been shown for other type III secretion systems. 
 
4.1.4. The type III secretion “inner membrane export machinery” 
YscR, S, T, U, V are five conserved essential components of type III secretion systems, which 
are thought to form the “export machinery” within the inner membrane. The exact 
localization, stoichiometry, and function of the proteins are unknown. 
We found that YscV, the largest of the five proteins, harboring a 40 kDa cytosolic domain, 
seems to play a specific role within this protein group. It has to be induced with significantly 
higher arabinose levels than its partners to complement the respective mutant strains, its 
cytosolic domain forms multimers in solution, and it is the only component of the inner 
membrane export machinery for which a fluorescent variant leads to observable membrane 
spots. 
Formation of YscV-EGFP foci at the cell periphery did not depend on the presence of the 
ATPase, suggesting that it is an independent event within the assembly. Interestingly, in a 
strain lacking the MS ring component YscJ, fluorescent spots appeared, but were highly 
motile within the membrane, indicating that YscV is anchored (most likely in the 
peptidoglycan layer) by attachment to the MS ring, directly or via another protein. 
The proposed oligomer formation of YscV would further imply a localization outside the MS 




4.2. Regulation of expression and  function of  the Yersinia  type 
III secretion system 
4.2.1. Promoter activity upon induction of type III secretion 
Regulation of T3S is in large parts poorly understood. Besides the immediate scientific 
interest in the influence of external factors on assembly and function of the injectisome, we 
also wanted to find out whether certain conditions or alterations in the genes encoding the 
regulator proteins could be used to boost the expression levels of T3S proteins. To get a solid 
data base for subsequent experiments, we first systematically studied promoter activity and 
overall protein levels of different injectisome components under various conditions.  
FACS  analysis  of  pVir  reporter  strains  shows  uniform  upregulation  of  T3S 
promoters upon temperature shift 
Most structural components of the Yersinia type III secretion machinery are located in three 
operons on the pYV virulence plasmid (see Figure 1.5): The virB operon contains eight genes, 
yscN to yscU; virC contains eleven genes, yscB to yscM1; and the translocator operon encodes 
LcrG, LcrV, LcrH, YopB, and YopD (Michiels et al., 1991; Lambert de Rouvroit et al., 
1992). The master regulator for T3S system gene transcription, also located on the pYV 
plasmid, is the transcription factor VirF (Lambert de Rouvroit et al., 1992).  
To assay the transcriptional activation of the three main operons and virF itself, four reporter 
plasmids were designed, each of which encodes for a triple GFP under the control of the 
promoters for virF, virB, virC, or the translocator operon. The activity of these promoters 
upon activation of the T3S by temperature increase to 37°C under secretion-permissive 
conditions was monitored by fluorescence activated cell sorting (FACS) analysis of the GFP 
fluorescence. 
Upon activation of the system by temperature shift, which leads to expression of VirF, the 
constructs harboring the promoter regions of the three machinery operons showed a uniform 
increase in fluorescence (Figure 4.1). Interestingly, pVirF was not influenced by the 
temperature increase, as the fluorescence of the pVirF::3gfp strain was even slightly below 
the start level after 4 hours at 37°C. This suggests that the remodeling of DNA structure that 
is thought to be responsible for the temperature dependence of VirF on the virulence plasmid 
did not affect the plasmid harboring the reporter construct. 
4.2  Supplementary results ‐ Regulation of expression and function  
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In comparison to the control vector, the strains harboring the reporter constructs displayed 
increased fluorescence even before the temperature shift (Figure 4.1 B). While this might 
reflect a certain basal expression level, it could also be caused by transcriptional leakage of 
the reporter constructs. However, an increase in fluorescence could be observed from 30 
minutes after the temperature shift on9. Afterwards, the GFP level steadily increased in a 
similar fashion for all three machinery operons, leading to a roughly three-fold higher 
fluorescence after 4 hours for all three strains. This shows that they are affected by VirF in a 
very similar manner.  
 
                                                         
9 GFP expression and folding requires some time, which might lead to a lag of the read-out in our 
experimental setup. However, other results (see chapter 3, Figure 3.6) indicate that GFP is expressed and 





















Figure  4.1:  Promoter  activity  of  the  operons  encoding  for  injectisome  subunits  develops 
similarly over time. 
A: FACS analysis of strains harboring the reporter constructs pAD123, pAD124, pAD125, or pAD126 
(pVirF::3gfp,  pTransl::3gfp,  pVirB::3gfp,  or  pVirC::3gfp,  respectively),  as  indicated.  Fluorescence 





These data suggest that the assembly of the T3S injectisome is not regulated by different 







To study how expression levels of the transcription factor VirF and the downstream T3S 
proteins evolve over time, and whether the amount of injectisome components could be 
increased by expression of VirF from an inducible promoter, a strain lacking VirF (AD4006) 
was generated and complemented for VirF expression in trans by plasmid pCL5, expressing 
virF under the control of the tac promoter (Lambert de Rouvroit et al., 1992). 
The experiment was performed under secretion-permissive conditions. While the level of 
plasmid-borne VirF showed a fast increase up to 60 minutes after induction, it stayed constant 
or even slightly decreased afterwards. In contrast, the level of endogenous VirF in the wild-
type strain MRS40 showed a sigmoid increase with the steepest slope from 60 to 120 minutes 
after induction. The protein level of the injectisome component YscF, expressed under VirF 
promoter control, developed in a very similar way (Figure 4.2). The ratio YscF/VirF was 
significantly higher, when VirF was expressed endogenously. The reason for this is unclear. 
The results show that VirF expression in trans leads to faster expression, but not to increased 
final levels of injectisome components under secretion-permissive conditions (Figure 4.2). In 
secretion-non-permissive conditions, it only leads to a weak increase in protein levels (data 
not shown). Expression of VirF in trans is therefore not suited to increase the amount of 
injectisome components under these conditions and was not applied in further experiments. 
Removal of  the negative  regulators YscM1/M2 does not  significantly  influence 
kinetics or amount of T3S protein expression 
As the negative regulators YscM1 and YscM2 have been shown to downregulate expression 
levels of the T3S proteins (Stainier et al., 1998), we generated a strain lacking VirF and both 






It was obvious that the absence of the negative regulators YscM1 and YscM2 in strain 
AD22705(pCL5) did not change the expression kinetics compared to the respective control 
strain AD4006(pCL5), and importantly did not result in an increase in protein expression. On 
the contrary, the levels of VirF and YscF were even reduced (Figure 4.2). For this reason, 
























in  secretion‐permissive  conditions  (BHI‐Ox).  Samples  were  taken  at  different  time  points  after 
induction  of  T3S  and  VirF  in  strains MRS40  (WT),  AD22705(pCL5)  [ΔvirFyscM1yscM2,  virF+]  and 
AD4006(pCL5)  [ΔvirF,  virF+].  B:  Quantification  of  the  temporal  development  of  the  protein 







It has been previously reported that chelation of calcium ions in the medium at 37°C leads to 
a strong increase in the synthesis of effector and translocator proteins (Stainier et al., 1998), 
as well as to an increase in the synthesis of machinery proteins (Allaoui et al., 1995b). The 
effect of extracellular calcium concentration on the production of needles was reported to be 
even more pronounced (Müller et al., 2005). However, despite anecdotal evidence for 
differential influence on different protein classes and needle formation, the impact of the 
external calcium level on the expression pattern of the injectisome components had never 
been systematically analyzed. To quantify the effect of extracellular calcium on expression 
levels, and to test whether different protein classes respond differently to changes in the 
extracellular calcium level, the protein levels of various T3S components covering different 
functional subunits were followed over time. Importantly, in these experiments, needle 
formation was monitored and quantified as well. 
The results show (Figure 4.3) that the protein levels of all tested injectisome components, 
covering basal body proteins as well as needle components and the molecular ruler YscP, are 
influenced by the extracellular calcium level in a similar fashion. Three to four hours after the 
induction of the system by temperature increase to 37°C, cellular protein levels reached a 
plateau. At this time, the amount of total cellular proteins (Figure 4.3, marked in gray) in 
bacteria incubated in non-secretion-permissive conditions was at 40-60% of the amount in 
bacteria incubated in secretion-permissive conditions. Interestingly, needle formation (Figure 
4.3, marked in green) also showed a two-fold increase only in secretion-permissive 
conditions, suggesting that the quantity of needle formation merely depends on the amount of 
basal body proteins. The lag of needle formation behind expression of YscF and LcrV 





































Figure  4.3:  Cellular  protein  levels  of  various  injectisome  components  and  the  amount  of 
needles  are  similarly  influenced by  extracellular  calcium  levels  and develop  likewise  over 
time. 
A:  Immunoblot  time course analysis of protein amounts  in  the  total  cell  fraction and  in purified 
needles, under secretion‐non‐permissive conditions (BHI+Ca2+, left side) and secretion‐permissive 
conditions  (BHI‐Ox,  right  side).  Asterisks  denote  unspecific  bands  in  the  immunoblot.  B: 
Quantification of  the  immunoblot bands  shown  in A. The 240 min value  in  secretion‐permissive 
conditions  has  been  set  as  100%.  Background  colours  indicate  cellular  protein  levels  (gray)  or 







Downregulation  of  T3S  after  transient  secretion  is  achieved  by  separate 
pathways  in  response  to  either  temperature  decrease  for  needle  assembly  or 
calcium addition for effector secretion 
Experiments on the regulation of T3S mainly focus on the establishment of secretion upon 
changes in the environment. In vivo, however, the opposite case – transition to non-secretion-
permissive conditions – is likely to be as important. Whether, and how, T3S is downregulated 
in these cases, is unknown. Therefore, in a series of experiments, the injectisome was first 
assembled under secretion-permissive conditions (37°C, BHI-Ox). Afterwards, the bacteria 
were subjected either to non-secretion-permissive conditions (BHI+Ca2+), or to low 
temperature, and the effect on the secretion pattern was observed over time. 
As Figure 4.4 A shows, bacteria that remained under secretion-permissive conditions (BHI-
Ox) at 37°C continued to export effectors and translocators, even to a higher extent than 
before. Bacteria that remained in BHI-Ox, but were incubated at 26°C, continued to export 
effector proteins for at least three more hours, but seemed to stop the export of proteins 
required for needle formation (YscF, LcrV, YscP, YopB, YopD), suggesting that they did not 
assemble new needles. In contrast, bacteria that stayed at 37°C, but were incubated in non-
secretion-permissive conditions (BHI+Ca2+), rapidly stopped the export of effector proteins, 
but kept exporting the proteins required for needle formation. 
To rule out that these effects were a mere consequence of the changes in cellular protein 
levels, immunoblot analysis of YscP, LcrV, YopE, and YscF was performed for cellular 
proteins (TC, Figure 4.4 B). The same was done for secreted proteins (SN, Figure 4.4 C), 
which allowed to verify the data of the previous experiments and to analyze the differences in 
export in more detail. As controls, cultures that were not pretreated (“initial cultures”) were 
included. Samples were taken three hours after induction of the system, or change of the 
medium, respectively (see Material and methods for experimental details). The cellular 
protein levels of the tested components in the initial cultures (Figure 4.4 B, left side) showed 
that expression was turned on by the temperature shift to 37°C, and the extracellular calcium 
level had a comparably small effect (see chapter 4.2.2). Afterwards, the cellular proteins 
levels stayed surprisingly unaffected by changes in temperature or calcium concentration 
(Figure 4.4 B, right side), confirming that the cellular levels of T3S proteins are not subject to 

































Figure 4.4: Export of proteins  required  for needle  formation and effectors  is  regulated by 
different external stimuli, independently of the cellular protein levels 
A: Time course of protein export (culture supernatant, SN) in the initial culture (37°, BHI‐Ox) and 
the  subsequently  shifted  cultures,  as  denoted.  Proteins  exported  in  BHI‐Ox,  irrespective  of  the 
temperature (effectors, see text) are printed in green font. Proteins exported at 37°, irrespective 
of the extracellular calcium level (translocators, see text) are printed in red font. The double band 









In contrast, the export of proteins was highly dependent on extracellular conditions. The 
proteins required for needle formation (YscF, LcrV, YscP) were released both in BHI+Ca2+ 
and BHI-Ox (but strongly temperature dependent), whereas effectors (YopE) were released 
independently of the temperature, but were fully dependent on low extracellular calcium 
levels, after injectisomes had been functional once (Figure 4.4 A, C). 
 
4.2.4. Discussion 
Formation of the injectisome (Allaoui et al., 1995b) and secretion of effector proteins 
(Stainier et al., 1998) are the two controlled steps of type III secretion. In this study, we have 
systematically observed both events under various conditions.  
As expected from the fact that transcription of the three main T3S operons depends on the 
presence of the transcription factor VirF (Michiels et al., 1991; Lambert de Rouvroit et al., 
1992), it is induced simultaneously. Using reporter gene constructs, we could further show 
that afterwards, promoter activities of the operons develop in the same way (Figure 4.1). The 
analysis of protein levels showed that this is also directly reflected in the cellular amounts of 
T3S components. Injectisome subunits expressed from different operons and exerting 
different functions display the same temporal development. Their amount depends on the 
amount of VirF (Figure 4.2) and reacts similarly to external cues (two-fold increase of 
expression in secretion-permissive conditions, Figure 4.3). This argues against a control 
through differences in protein stability or specific degradation mechanisms. In conclusion, all 
components of the T3S system are present in a defined ratio over time. Importantly, we could 
show that the amount of needle formation also parallels the expression levels of T3S 
components (Figure 4.3). This clarifies that extracellular calcium has the same effect on the 
expression of all T3S components and the formation of needles (Allaoui et al., 1995b; 
Stainier et al., 1998; Müller et al., 2005). The data also suggest that the number of 
injectisomes is similarly controlled by the extracellular calcium level, even though this could 
not be directly assayed. 
Once expression has been turned on by temperature shift to 37°C, the protein levels for all 
tested T3S components stay remarkably unaffected by external influences (Figure 4.4 B). 
However, our results show for the first time that both the secretion of effectors and of 
components needed for needle assembly (YscF, LcrV, YopB, YopD, YscP) are tightly 
controlled and can be shut down quickly in response to changes in the environment (Figure 




Effectors are continuously being exported once secretion has been established, as long as no 
Ca2+ is present in the medium. This finding also shows that injectisome function does not 
depend on temperature. However, addition of calcium blocks effector secretion within a short 
time, presumably through reassembly of the secretion plug. How the calcium level is sensed, 
how the signal is transferred, and how the fast plug assembly occurs mechanistically, remains 
unknown. In clear contrast to this, export of the components required for needle assembly 
strongly depends on the temperature, whereas the dependence on the calcium level is less 
pronounced. During the course of these studies, a similar differential effect of the calcium 
level on export has also been described for P. aeruginosa (Cisz et al., 2008). However, our 
finding that export of the proteins needed for needle assembly (and, presumably, needle 
formation itself) only occurs at 37°C, despite the presence of the respective proteins even at 
lower temperatures, suggests an added regulation mechanism beyond the translational control, 
which prevents needle formation at low temperatures10. 
Taken together, we could show that needle formation and effector secretion are differently 
controlled by independent mechanisms that can be put back into function after their release. 
Type III secretion is therefore not a one-shot deal, but can be regulated both on the level of a 
single injectisome (by blocking effector secretion upon calcium addition) and on the cellular 
level (by halting de novo needle formation upon decreased temperature). 
                                                        
10 If one needle is formed by each basal body, this temperature regulation mechnism could be exerted on 
any of the steps of injectisome assembly, not only on needle formation itself. However, as shown in the 
next chapter (Figure 4.11), assembly of YscC is not affected by low temperature, so that the regulation acts 











Fusions to fluorescent proteins are an excellent way to study protein localization and kinetics. 
However, fluorescent proteins are relatively large and in order to minimize the influence of 
the tag on protein localization and function, a suitable combination of fusion protein and site 
has to be found. 
In the course of this study, we constructed various fusions to injectisome proteins, either with 
small affinity tags or with fluorescent proteins. Table III shows the fusion proteins that were 









YscC  Secretin (OM)  mCherry  (1)  C terminus  MA4005  + 
His8‐FLAG‐X8   (2)  N terminus  AD4049  + YscD  MS ring (IM) 
EGFP  N terminus  AD4050  (+) 
Gly4‐FLAG‐His8  C terminus  AD40085  + 
FlAsH  (3)  C terminus  AD4058  ‐ 
YscJ  MS ring (IM) 
EGFP  C terminus  AD40083  ‐ 
FLAG‐His8‐X8  N terminus  AD4136(pAD190)  + 
EGFP  N terminus  AD4136(pAD182)  + 
YscN  ATPase 
(cytosol)  (4) 
EGFP  C terminus  AD4136(pAD181)  ‐ 
His8‐FLAG‐X8  N terminus  AD4014  + 
EGFP  N terminus  AD4016  + 
YscQ  C ring 
(cytosol)  (4) 
















All tags were introduced onto the pYV virulence plasmid by homologous recombination, 
leaving the hybrid genes in their original genetic environment under the native promoter. 
Fusions to yscN that were introduced this way caused a reduction in the expression of 
downstream genes (data not shown). Therefore, as an exception, a non-polar deletion in yscN 
was generated, which could be complemented with the fusion proteins in trans. 
YscC has a predicted N-terminal sec signal sequence and is proposed to be anchored within 
the OM with its conserved C-terminal half. Most GFP derivatives do not fold properly in the 
periplasm due to the oxidizing conditions and subsequent non-native formation of a disulfide 
bridge (Feilmeier et al., 2000). As the introduction of a red fluorophore additionally allowed 
the colocalization of components, mCherry was fused to the C terminus of YscC. To generate 
a non-polar mutant, the ribosome binding site of YscD had to be reinserted after the tag (M. 
Amstutz, unpublished data). YscC-mCherry was fully functional for secretion (see Figure 
3.1). 
YscD does not have a predicted signal sequence. The N terminus of YscD is predicted to be 
localized in the cytosol, thus allowing the fusion of EGFP. The functionality of EGFP-YscD 
was decreased. Most likely, this was due to steric clashes, as both the combination of EGFP-
YscD with a deletion in YscJ, and the fusion of a small His8-FLAG tag to YscD did not 
impede its assembly and function (Figure 3.2, see also chapter 4.4, Figure 4.17). During the 
course of this study, the Shigella homologue MxiG was shown to be functional with a small 
N-terminal tag as well (Zenk et al., 2007). 
YscJ is a mainly periplasmic lipoprotein with a predicted transmembrane helix at the extreme 
C terminus, which is followed by a short cytoplasmic domain of only four amino acids. As 
this transmembrane helix is absent in homologues of YscJ, including EscJ, we assumed that it 
is unlikely to be involved in protein-protein interactions, making it a suitable location for the 
fusion of proteins. However, large tags rendered YscJ non-functional, most likely due to steric 
problems, as small tags did not affect functionality (Figure 4.5). Surprisingly, introduction of 
a twelve amino acid tetracysteine tag (Tsien, 2005) completely abolished the function of YscJ 






YscN, as a cytosolic protein, does not have a signal sequence. For this reason, EGFP was 
fused both to the N terminus and to the C terminus. The C terminal fusion was less stable and 
non-functional (Figure 4.6), whereas EGFP-YscN complemented the deletion and showed 




YscQ, like YscN, does not have a signal sequence. As it had been successfully affinity-tagged 
for antibody production before, and remained functional with an N-terminal tag (I. Sorg, 
personal communication), the tags were fused to the N terminus. To facilitate colocalization 
with other components, both mCherry and EGFP were used as fluorophores. While all fusions 
of YscQ retained their functionality, mCherry-YscQ localization was less focused than EGFP-
YscQ fluorescence (Cattin, 2009). 
Figure 4.5: YscJ remains functional 
with small C‐terminal tags. 
A:  Immunoblot  with  antibodies 
against  YscJ,  showing  the  size  and 























Assembly  and  colocalization  of  injectisome  components  are  independent  of 
temperature and extracellular calcium level and remain stable over time 
As expected from the fact that the formation of EGFP-YscQ spots was not strongly 
influenced by extracellular calcium levels (Figure 3.1), neither the assembly of YscC-
mCherry (M. Amstutz, unpublished data), nor of EGFP-YscD (Figure 4.7) showed a 




Irrespective of the extracellular calcium levels, EGFP-YscD fluorescence within the foci is 
lower than EGFP-YscQ fluorescence. Further, there is less EGFP-YscD present in the cell 
than EGFP-YscQ (see chapter 3.9, Supplementary Figure 1). This might display a lower 
stoichiometry for YscD than for YscQ. However, strains expressing EGFP-YscD are impaired 
in effector secretion; thus it cannot be excluded that the stoichiometry of EGFP-YscD is lower 
than for WT YscD.  
As shown in chapter 3, the most proximal tagged injectisome component, EGFP-YscQ, 
colocalized with the outer membrane ring component YscC-mCherry, as well as with the 
needle subunit YscF in wild-type Yersinia under normal conditions (induction of the T3S by 
temperature shift to 37°C in either secretion-permissive or non-permissive conditions). 
When bacteria were subjected to secretion-non-permissive conditions after transient secretion, 
differential downregulation of needle formation (at low temperatures) and effector secretion 
(upon calcium addition) was observed (chapter 4.2.3).                                                         
11 As EGFP-YscN was expressed in trans, the effect of the extracellular calcium level could not be assayed 
with this method. 
Figure  4.7:  The  extracellular  calcium  level  has 
no  detectable  influence  on  the  localization  of 
the tested injectisome components. 
Fluorescence  micrographs  of  bacteria  expressing 
EGFP‐YscQ  (AD4016,  upper  panels)  or  EGFP‐YscD 
(AD4050,  lower  panels)  under  secretion‐non‐
permissive  and  secretion‐permissive  conditions 





To find out whether these phenotypes are caused by, or at least reflected in, a different 
localization pattern of injectisome components, bacteria expressing both EGFP-YscQ and 
YscC-mCherry were observed under the fluorescence microscope after they had been first 
incubated for 3 hours at 37°C in secretion-permissive conditions and then were subjected to 
lower temperature (26°C) and / or calcium-containing medium (BHI+Ca2+, see chapter 4.2.3 
and Material and methods for details). 
As shown in Figure 4.8, neither the decreased temperature (leading to a stop in export of 
needle subunits), nor the addition of calcium (leading to a blocking of effector secretion) or a 
combination of both conditions led to an observable change in the localization pattern or to 
dissociation of the C ring spots and the secretin spots. Therefore, these two phenotypes are 
neither caused by a dissociation of the cytosolic components of the injectisome, nor lead to 





Assembly  of  the  MS  ring  can  be  detected  60  minutes  after  T3S  induction; 
subsequent steps occur within short time. 
As shown in Figure 3.6, formation of the C ring, a late step in the assembly of the 
injectisome, can be observed 60 minutes after induction of the T3S. To scrutinize the kinetics 
of the events before C ring formation, similar microscopy time course experiments using the 
Figure  4.8:  Colocalization  of  EGFP‐YscQ 
and  YscC‐mCherry  remains  stable  three 
hours  after  addition  of  calcium  or 
decrease of temperature. 
Fluorescence  micrographs  of  bacteria 
expressing  EGFP‐YscQ  and  YscC‐mCherry 
(MAAD4006)  that  have  been  incubated  at 
37°  under  secretion‐permissive  condition 
(BHI‐Ox)  and were  subsequently  incubated 
under  secretion‐non‐permissive  or 
secretion‐permissive  conditions  (BHI+Ca2+ 
or  BHI‐Ox),  at  26°  or  37°,  as  denoted. 





other fluorescent constructs were performed. Formation of the first YscC-mCherry secretin 
rings could not be observed, as the background in the red fluorescence channel prevented the 
detection of the weaker early spots (data not shown). The formation of EGFP-YscN spots was 
not examined as the in trans expression of this protein might lead to artefacts in the assembly 
kinetics. In contrast, formation of EGFP-YscD spots could be observed. As for EGFP-YscQ, 
the first spots were visible 60 min after T3S induction. As already observed in Figure 4.7, 
both the increase in cytoplasmic formation and the intensity of spots is less pronounced than 
shown for the C ring component. However, the kinetics are very similar, suggesting that 
formation of the ATPase – C ring complex occurs fast after establishment of the MS ring and 




At the same time as the formation of the first C ring spots, the first needles can be observed, 
and effector secretion starts (Figure 3.6). We had assumed that needle formation requires 
presence of the ATPase – C ring complex, but to formally show the order of these events, a 
needle purification was performed in strains lacking YscN or YscQ (Figure 4.10). No needles 
could be observed in the mutant strains, showing that indeed, the ATPase and the C ring are 
required for the formation of the needle. Therefore, needle formation and effector secretion 















Time  course  of  bacteria  expressing  EGFP‐YscD  (AD4050)  under  secretion‐non‐permissive 





A recent paper by Konishi et al. (2009) showed that the requirement of the flagellar C ring 
subunits FliM and FliN for the formation (but not the function) of the flagellum could be 
overcome by overproduction of the ATPase FliI. To test whether this also holds true for the 
injectisome, the homologous ATPase YscN was overproduced in trans in a strain lacking 
YscQ (Figure 4.10, right side). Even at an induction with 0.5% arabinose, ten times the 
amount required for a wild-type level of YscN, the amount of needle proteins was not 
increased compared to the uninduced control strain. This is accordance with the proposed 






As the assembly steps following MS ring formation seem to occur within a short time frame 
after 40-60 min (Figure 3.6), and do not merely reflect the expression pattern of the respective 
proteins (Figure 4.3), rate-limiting steps have to exist within the early injectisome assembly. 
Formation of the secretin ring is one of most complex steps in injectisome formation: It forms 
the first oligomer and the first ring structure of the injectisome, it has to be delivered from the 
IM to the OM by its pilotin YscW, and it bridges the peptidoglycan layer. Secretin formation 
thus was a candidate for the rate-limiting step in injectisome formation. Since YscC assembly 
could not be directly assayed by analysis of a fluorescent variant, pre-induction experiments 
were performed. As an earlier completion of a rate-limiting step would expedite all 
subsequent steps, effector secretion was chosen as a simple and unambiguous read-out. 
Figure  4.10:  Needle  formation  and  effector 
secretion requires presence of YscN and YscQ and 
cannot be  restored by overexpression of  YscN  in 
strains lacking YscQ. 
Upper  panels:  Immunoblot  analysis  using  antibodies 
directed against  the needle  tip  component  LcrV and 
the  needle  subunit  YscF  in  needle  preparations  of 
strains  MRS40  (WT),  AD4136  (ΔYscN),  ISOA4015 
(ΔYscQ),  or  ISO4015(pAD165)  (ΔYscQ  +  pBAD‐yscN), 





Strain ADMA4098 (ΔYscC) was complemented in trans by pMA6 (YscC under an inducible 
promoter) and pRS6 (YscW under a constitutive promoter). YscC was induced with 0.05% 
arabinose, which complements for effector secretion (M. Amstutz, personal communication). 
This was done either one hour before induction of the remaining injectisome components by 
temperature shift to 37°C, at the same time, or one hour after induction of the remaining 
components. As a control, an uninduced strain was used. 
As visible in Figure 4.11 A, pre-induction of YscC did not lead to earlier effector export. 
However, the strain in which YscC was induced one hour after the temperature shift showed a 
secretion pattern that resembled the patterns of the other strains 30 – 60 minutes before. As 
expected, the uninduced control did not show any secretion. 
To rule out that the secretin ring does not assemble at temperatures below 37°C, which would 
prevent its formation in the pre-induction time course, YscC-mCherry was expressed together 
with YscW in a strain cured of the virulence plasmid (pYV-(pMA8, pRS6)) at 26°C and 37°C, 
and formation of fluorescent spots was monitored three hours later. Figure 4.11 B shows that, 
even though the fluorescent spots appear brighter at 37°C (which might be a consequence of 





















with  temperature  shift;  PI3,  YscC  induction  1  h  after  temperature  shift;  n.ind.,  not  induced. B: 








These results confirm that the presence of YscC is a crucial prerequisite of the further events, 
as shown by the delay in secretion caused by the later YscC induction. However, assembly of 
the secretin ring alone does not expedite the following steps, which in the absence of further 
candidates suggests that assembly of YscD is at least part of the rate-limiting step.  
 
4.3.3. Dynamics of the injectisome basal body 
FRAP  experiments  indicate  dynamic  exchange  of  subunits,  but  no  function  in 
substrate shuttling for EGFP‐YscQ 
For the cytosolic subunits of the flagellum, a model has been proposed in which the ATPase 
is involved in the transport of substrates from the cytosol to the C ring, and from there to the 
export channel (Minamino et al., 2008). Our results indicate that in the injectisome, the C ring 
and the ATPase assemble in one complex (chapter 3). As, further, the injectisome C ring is 
not required for the rotational switch, and has been proposed to serve as a “central hub of 
protein-protein interactions” in Chlamydia (Spaeth et al., 2009), we tested the possibility that 
YscQ localizes dynamically to the proximal side of the injectisome, possibly participating in a 
shuttling mechanism. 
To assay this hypothesis, we performed a fluorescence recovery after photobleaching (FRAP) 
experiment, in which the fluorescence of single EGFP-YscQ foci was bleached, and the 
recovery of the foci was observed over time. The strain used in this experiment, AD4085, 
expresses EGFP-YscQ in a strain that can be grown in a safety class I environment (see 
chapter 7.3 for details). It was functional for secretion and EGFP-YscQ localization did not 
differ from strain AD4016 (EGFP-YscQ in wild-type background, data not shown). 
Fluorescence at the foci within the bleached area reappeared with a recovery half-time of 4.26 
min (+/- 1.02 min) for EGFP-YscQ (Figure 4.12, see Table IV for details). While this 
indicates a faster subunit exchange than for the flagellar MS ring component FliF-YFP that 







































in  strain  AD4085.  Red  circles  indicate  the  approximate  borders  of  the  bleached  area.  B: 
Quantification  of  spot  fluorescence  and  extrapolation  of  recovery.  See  table  IV  for  details.  C: 












0  43.788  66.309  125.156  1.000  4.56  0.973 
0.25  42.629  54.446    52.899  0.000      
1  44.079  52.002    55.452  0.206      
4  42.694  56.219    73.915  0.525      
A 
10  43.212  56.727    83.829  0.779       
0  51.510  88.314  122.652  1.000  5.10  0.900 
0.25  47.577  73.556    76.609  0.000      
1  43.551  68.717    70.780  ‐0.044      
2  41.856  66.083    75.138  0.314      
3  42.455  66.305    75.471  0.327      
5  48.500  75.478    89.647  0.500      
7  53.403  76.143    87.859  0.488      
B 
10  57.193  82.473  102.198  0.813       
0  55.251  89.781  117.364  1.000  3.13  0.956 
0.25  51.303  76.978    62.589  0.000      
1  52.237  75.431    68.655  0.197      
2  51.323  73.387    72.518  0.383      
3  50.749  74.590    78.840  0.543      
5  52.543  77.237    89.165  0.768      
7  49.778  76.901    89.421  0.752      
C 
10  55.830  88.165  114.884  1.020       
 
Table IV: Fluorescence recovery after the photobleaching of EGFP‐YscQ foci. 
The  average  value  for  t½(recovery)  is  4.26  min  (+/‐  1.02  min).  The  normalized  fluorescence  values  were 
obtained  by  calculating  the  ratio  of  background‐corrected  fluorescence  intensities  in  the  area  of  the 
bleached  spot  and  in  the  complete  cell,  which  accounts  for  variations  in  total  fluorescence  due  to 
bleaching  effects.  Subsequently,  the  fluorescence  ratio was  normalized  using  the  pre‐bleach  and  post‐







YscQ and YscN simultaneously assemble at the proximal side of the injectisome as part of the 
large cytosolic ATPase - C ring complex (chapter 3). Whether this complex already forms in 
the cytosol, or requires the MS ring as assembly platform, is unknown. To study this question, 
the combination of mCherry-YscQ and EGFP-YscN was tested in FRET experiments. GFP 
and mCherry have been shown to be applicable as FRET pair with an efficiency similar to the 
widely used CFP/YFP (Tramier et al., 2006; V. Sourjik, personal communication). In case of 
a positive FRET result for the strain lacking only YscJ, this setup would allow to study the 
roles of YscK and YscL in assembly and localization of the ATPase – C ring complex. 
The results of the experiments are summarized in Figure 4.13. To ensure the cytoplasmic 
localization of the proteins, all strains used lack the MS component YscJ. The control strains 
for cytoplasmic fluorescence of mCherry-YscQ or EGFP-YscN alone (ADCC4148 and 
AD4139(pAD182), respectively) were tested for fluorescence in the red, green, and FRET 
channel (GFP excitation, mCherry emission, see Material and methods for details). While the 
green and red channel were tightly separated, both EGFP and mCherry caused a background 
signal in the FRET channel (12.3% +/- 1.4% and 12.6% +/- 1.4% of the respective 
fluorescence signal, see Figure 4.13 A, Table V), as expected from the excitation/emission 
spectra of the fluorophores (Figure 4.13 B). The strain expressing both fluorescently labeled 
proteins, ADCC4148(pAD182), showed a fluorescence level in the FRET channel that was 
slightly below the sum of the expected background signals caused by the two single 
fluorophores (see Table V for details). This indicates that there is no energy transfer between 
mCherry-YscQ and EGFP-YscN. Whether this is caused by large distance or sterical 
mismatch between the fluorophores, or shows that there is no pre-formation of the ATPase – 
C ring complex in the cytosol, cannot be concludingly distinguished due to the lack of 
structural data for the complex. A copurification approach based on the affinity tagged 














ADCC4148  ‐  +         3.73       68.35         8.41 
AD4139(pAD182)  +  ‐       35.41         0.23         4.45 





Figure  4.13:  FRET measurements  do  not  indicate  energy  transfer  between mCherry‐YscQ 
and YscN‐EGFP. 
A:  FRET  results  for  strains  ADCC4148  (ΔYscJ,  ΔYscN,  mCherry‐YscQ),  AD4139(pAD182)  (ΔYscJ, 
ΔYscN  +  pBAD‐yscN‐egfp),  and  ADCC4148(pAD182)  (ΔYscJ, ΔYscN,  mCherry‐YscQ  +  pBAD‐yscN‐
egfp).  Green  bars:  GFP  fluorescence;  red  bars:  mCherry  fluorescence;  yellow  bars:  FRET  signal 
(excitation  GFP,  emission  mCherry).  B:  Fluorescence  excitation  (dashed  line)  and  emission 
(continuous  line)  spectra  for  GFP  (green)  and  mCherry  (red)  (adapted  from  Keck  Microscopy 





Formation of the injectisome after induction of the T3S system by temperature increase to 
37°C is a relatively slow process. Needle formation and effector secretion can only be 
observed after 60 minutes (Figure 3.6 B, C). To learn about the kinetics and possible 
checkpoints of the assembly process, we performed a series of experiments to define the rate-
limiting step in the assembly of the injectisome. We could show that, despite the earlier 
presence of all tested injectisome components (Figure 4.3 A), assembly of both the C ring 
(EGFP-YscQ, Figure 3.6 A) and the MS ring (EGFP-YscD, Figure 4.9) also only can be 
observed after 60 minutes. This restricts the possible rate-limiting step to one of the earliest 
events in assembly – the possible degradation of the peptidoglycan layer, multimerization or 
OM integration of the secretin YscC, or assembly of YscD. However, pre-induction of YscC 
in the presence of its pilotin YscW did not expedite the later events (Figure 4.11), showing 
that YscC assembly is not the sole rate-limiting step. This is in agreement with previous 
pulse-chase experiments (Burghout et al., 2004a), where oligomerization of YscC was 
observed already after 5 – 30 minutes. The integration of YscC into the OM was not tested in 
this study. Therefore, it cannot be excluded that this step is rate-limiting in combination with 
YscD attachment. This would also agree with the fact that delayed YscC expression also led 
to deferral of the following steps. Effector secretion lagged by 30-60 min when YscC was 
expressed 60 min after T3S induction. This time is in perfect agreement with data observed 
for the type II secretion secretin ExeD in Aeromonas hydrophila, where export of the 
substrate aerolysin was observed 40-60 min after induction of ExeAB, which are suggested to 
exert the pilotin function (Ast et al., 2002). To determine whether YscC integration in the OM 
and YscD assembly really jointly constitute the rate-limiting step in the assembly of the 
injectisome, a construct expressing both proteins would have to be pre-induced in the 
presence of YscW. This construct has been created and verified, but could not be tested in a 
time course experiment yet. 
Moreover, we could show that for neither of the tested proteins EGFP-YscD and EGFP-
YscQ, the extracellular calcium level had an influence on the localization pattern (Figure 4.7), 
The same could be observed for YscC-mCherry (M. Amstutz, unpublished data). Our results 
for the colocalization of the secretin and the C ring under different conditions, after the 
transient incubation of bacteria under secretion-permissive conditions, further indicate that the 
injectisomes are stable for hours, even at low temperature and in the presence of calcium. 
This agrees with the functionality of the system under these conditions (Figure 4.4), and 
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shows that the observed change in substrate specificity is neither caused by, nor reflected in 
dissociation of the cytoplasmic components. 
To test whether the cytosolic components of the injectisome participate in a cargo shuttling 
mechanism, as has been proposed for the flagellar ATPase complex FliH2FliI (Minamino et 
al., 2008), we tested the dynamics of EGFP-YscQ by FRAP. Despite the clear result of the 
experiment, the interpretation of the data is difficult. The measured recovery half-time 
(equivalent to the exchange of 50% of the bleached subunits of the C ring with fluorescent 
subunits) of several minutes (Figure 4.12 A, B) appears to be too slow to be compatible with a 
dynamic shuttling mechanism. The C ring component is only slightly more dynamic than the 
structural subunits of the flagellar MS ring (FliF, see Figure 4.12 C), and C ring, where a 
recent publication shows that in a rotating flagellum, the two components FliM and FliN 
exchange subunits “in tens of minutes”, whereas FliG does not show a detectable subunit 
exchange (Fukuoka et al., 2010). In a study examining the dynamics of the nuclear pore 
complex (Rabut et al., 2004), an exchange rate of t½ = 4.4 min, similar to the one we observed 
for YscQ, was detected for the most dynamic structural component gp210, whereas the 
importin, which shuttles substrates, had a recovery halftime of below 2 seconds. In 
conclusion, the C ring component YscQ does not seem to be involved in substrate shuttling, 
but shows a comparably high subunit exchange, which suggests a low structural stability for 








Needle complexes have been purified from various organisms. The protocol that has been, 
with slight modifications, applied in all these cases, consists in spheroplast generation by 
lysozyme / EDTA treatment, lysis by addition of detergent, and subsequent purification by 
ultracentrifugation (Kubori et al., 1998; Kimbrough and Miller, 2000; Blocker et al., 2001; 
Sekiya et al., 2001; Marlovits et al., 2004; Ogino et al., 2006). This protocol, however, did 
not lead to the purification of injectisomes in Y. enterocolitica (S.-I. Aizawa, personal 
communication; own unpublished data). One possible reason for this is that needles either 
detach or depolymerize under the given conditions. A needle preparation screen at different 
pH values revealed that Yersinia needles could not be purified at pH above 8.0 (Figure 4.14). 
In order to create Yersinia spheroplasts in conditions under which the needles are stable, the 
protocol therefore had to be adapted to a lower pH of 7.8, which required a significant 












Needle  preparations  were  performed  at  different  pH  values  (see  Material  and  Methods  for 






However, the Yersinia spheroplasts quickly aggregated under these conditions, which led to a 
decreased efficiency of cell lysis and, even more pronounced, of solubilization of injectisome 
components. To overcome this problem, the Yersinia adhesin YadA was removed by 
integration of the mutator plasmid pLJM31 into the yadA gene.12 
Surprisingly, the resulting strains showed weak growth (Figure 4.15 A) due to partial lysis 
(Figure 4.15 B) after induction of the T3S under standard conditions. However, this could be 
completely prevented when the carbon source was exchanged (0.4% glycerol instead of 0.4% 
glucose). It thus seems the glucose taken up from the medium was converted to sucrose, 
which subsequently was polymerized to toxic levels of levan, due to the presence of the 
levansucrase gene on the integrated yadA mutator plasmid. In subsequent experiments, 




When incubated under these conditions, cells lacking YadA (Figure 4.16 A) did not aggregate 
after spheroplast formation (Figure 4.16 B), leading to complete lysis of the bacteria at a 
Triton X-100 concentration of 0.75% (data not shown).                                                         
12 Unlike most other T3S components in Yersinia, YadA is not part of a larger operon and can therefore be 



















To purify parts of the Yersinia injectisome basal body and examine the role of different 
proteins by the comparison of deletion mutants, a purification method which is not based on 
physicochemical properties had to be applied. To achieve a high enrichment under gentle 
conditions, a tandem affinity purification (TAP) tag approach (Gavin et al., 2002) was applied 
using small affinity tags that are less likely to disturb protein function and complex formation 
(Yang et al., 2006). During the course of these studies, a paper describing the affinity-based 
purification of the Shigella needle complex (Zenk et al., 2007) confirmed the general 
applicability of this strategy. 
In the basal body, the two proposed components of the MS ring, YscD and YscJ, were tagged 
with either a His8 tag, a FLAG tag (DYKDDDDK) (Chubet and Brizzard, 1996), or a 
combination of both. While larger tags in the same position led to a decrease or complete 
abolishment of effector secretion (see Table III, Figure 3.1, Figure 4.5), the used affinity tags 
with a molecular weight below 3 kDa did not impair the function of the proteins (Figure 
4.17). 
Surprisingly, although both YscJ-His8 and FLAG-YscD (strains AD40082, AD4047) were 
functional, a combination of both tagged proteins led to a complete abolishment of secretion 
(Figure 4.17). This suggests that the C terminus of YscJ and the N terminus of YscD are in 
close proximity in the cytoplasmic part of the injectisome structure. A direct steric clash of 
the tags is unlikely, as tags on one protein, with the length of both single tags, are still 








position  of  the  YadA  trimer 
is marked  by  an  asterisk.  B: 
Micrograph  showing  the 





functional (Figure 4.17). However, the proximity might lead to a non-productive interaction 
between the (mildly positively charged) His tag and the (negatively charged) FLAG tag which 





Specific copurification of the basal body components is likely to depend on crosslinking of 
the proteins. As the crosslinker used for this purpose had to be membrane-permeable and 
preferably cleavable, para-formaldehyde (FA) and Dithiobis[succinimidyl propionate] 
(Lomant’s reagent, DSP) were compared for their applicability. 
In a comparison of different concentrations of FA and DSP for their effect on copurification 
of YscC and YscD with YscJ-FLAG-His8, after the gentle resuspension of cells in PBS, 0.5% 
FA and 2.0 mM DSP yielded the best results (Figure 4.18). As DSP led to a decrease in lysis 
efficiency (data not shown), FA was used in the subsequent experiments. 
Since crosslinking also had an obvious influence on spheroplast generation and cell lysis, the 
optimal FA concentration and time point of crosslinking were determined. Different 
concentrations of formaldehyde were used either directly in the bacterial culture, or after 





A:  Immunoblot  analysis  of  cellular  proteins  using  antibodies  directed  against  YscD  and  YscJ  in 
strains  MRS40  (WT),  AD40082  (YscJ‐His8),  AD4047  (FLAG‐YscD),  AD4048  (FLAG‐YscD,  YscJ‐His8), 
and  AD4049  (FLAG‐His8‐YscD).  Expected  protein  sizes:  H,  His‐tagged  protein;  F,  FLAG‐tagged 






As visible in Figure 4.19, lysis efficiency (as determined by measurement of the optical 
density at 600 nm) varied from 37% - 99%. Overall, the washing step in PBS significantly 
increased lysis efficiency. Further, there was an optimum in formaldehyde concentration at 




To achieve efficient crosslinking while retaining high lysis rates, the following protocol was 
applied in subsequent experiments: Crosslinking with 0.25% FA in the culture; gentle 
resuspension in PBS; crosslinking with further 0.4% FA (see Material and methods for 
details). This treatment consistently led to good crosslinking and high lysis efficiency. 
Figure 4.18:  
Influence  of  different 
crosslinking  conditions  on  the 
copurification  of  the  membrane 
ring proteins 
Immunoblot  analysis  of  the 
copurification  of  YscC  and  YscD 
with  YscJ‐FLAG‐His  in  strain 
AD40085  after  crosslinking  with 
the  given  concentrations  of 
crosslinkers  Dithiobis[succinimidyl 
propionate]  (DSP)  or  para‐
formaldehyde (FA). 










Influence of different  crosslinking  conditions on  the  copurification of  the membrane  ring 
proteins 
Immunoblot  analysis  of  the  copurification  of  YscC  and  YscD  with  YscJ‐FLAG‐His  in  strain 






















As shown in chapter 3, the proteins forming the membrane rings within the basal body can be 
copurified using affinity tagged YscD or YscJ. While a one-step FLAG purification was 
sufficient to copurify the three membrane ring proteins and to show the requirements for this 
copurification, TAP decreased the unspecific background and was therefore used to assay the 
copurification of further injectisome components. 
The result of such a two-step purification (Ni2+ affinity followed by FLAG affinity, see 
Material and methods for details) is shown in Figure 4.20. After the second purification step, 
the sample contained a large amount of the tagged protein YscJ-FLAG-His8, which is visible 
as the most intense band on the silver stained gel. The two copurified proteins YscC and 
YscD (identified by comparison of band intensity and location to an immunoblot of the same 
samples) were visible as well, albeit in significantly lower concentrations. Several bands that 
could not be unambiguously assigned (marked by asterisks) were still present in this fraction. 
The higher intensity of the tagged YscJ, compared with the copurified proteins, indicates that 
monomeric cytosolic YscJ was purified with this protocol as well, besides partially or fully 




Figure  4.20:  TAP  purification  of 
strain AD40085 (YscJ‐FLAG‐His8). 
Silver  staining  of  a  12%  SDS‐PAGE 
gel,  lanes: 1, cellular proteins before 
crosslinking; 2, cellular proteins after 




affinity  column.  Asterisks  mark 
bands  in  lane  6  that  could  not  be 
unambiguously  assigned.  Note  that 
the highest MW band marked by an 






To test whether additional injectisome components were copurified, the outcome of a TAP 
purification of strain AD40085 (YscJ-FLAG-His8) was analyzed by mass spectrometry. 
To decrease the risk of false positive results, all following quality criteria had to be met for a 
protein to be considered as specifically copurified: 
• At least five different matched peptides per protein 
• E value < 10-4 (for search of nr database) / < 10-7 (for search of T3S protein database)13 
• Amongst top 50 hits from search against nr database 
 
Table VI shows the detected proteins. The presence of the three known purified proteins 
YscC, YscD, and YscJ shows the specificity of the purification and detection methods. Beside 
these three membrane ring-forming proteins, only YscV matched the quality criteria. All of 
these proteins were amongst the twenty most abundant proteins (including different isoforms) 
detected by mass spectrometry in a search against the nr database. Contaminants that were 
detected were either directly linked to the purification procedure (various isoforms of 
lysozyme, IgG, protein A) or highly abundant proteins (keratin, pyruvate dehydrogenase). 
The only unspecific hit for a Yersinia protein was the abundant OM protein YadA (Hoiczyk et 
al., 2000). Further T3S proteins that were detected, but did not meet the quality criteria, were 
YscR and YscU (data not shown). 
 




were  manually  curated  for  different 
isoforms of the same proteins. Components 
of  the  injectisome  are  denoted  in  bold. 
Ranking and E values were calculated by the 




13 The nr (non-redundant) database includes all GenBank, RefSeq Nucleotides EMBL, DDBJ, and PDB 
protein sequences. The T3S protein database includes all proteins which are encoded on the pYV plasmid 














Copurification of YscV with the ring proteins could not be confirmed by immunoblotting, 
probably due to the low specificity of the YscV antibody. However, the highest MW band in 
the silver stained TAP gel (Figure 4.20) matches the MW of YscV (77.9 kDa). The detection 
of YscV is even more plausible because data suggests that YscV is present more than once in 
each injectisome (see chapter 4.5). 
The needle subunit YscF was not detected in the mass spectrometry experiment. However, 
YscF is a very small protein (9 kDa) that contains only five peptides possibly detectable by 
mass spectrometry, and might therefore have been missed in this analysis. To specifically test 
for the copurification of YscF, a FLAG purification was performed for strains tagged at YscD 
(AD4055) or YscJ (AD4054). As controls, an untagged strain (LJM4029), and tagged strains 
lacking the OM secretin YscC (ADMA4101, AD4109, tagged at YscD and YscJ, 
respectively) were used. 
A small amount of YscF copurified with the strain tagged at YscD, a larger amount with the 
strain tagged at YscJ (Figure 4.21). YscF was absent in all control strains. The amount of 
copurified YscF in strains AD4055 and AD4054 corresponded to the amount of copurified 
YscC (not shown). The copurification therefore seems to be specific. However, the 
concentration of YscF was low, and its copurification was not observed in all experiments. By 






The same purification samples were analyzed for copurification of the cytosolic components 
YscN and YscQ. Neither of both proteins could be detected (data not shown), suggesting that 
the cytosolic ATPase – C ring complex copurifies very poorly with the membrane rings under 
these conditions, if at all. This observation is in accordance with purification data from other 
organisms (Kubori et al., 1998; Tamano et al., 2000; Sekiya et al., 2001). 
Figure  4.21:  Copurification  of  YscF  with  affinity 
tagged YscD or YscJ 
Immunoblot  analysis  of  YscF  in  the  FLAG  elution 
fraction  of  strains  AD4055  (His‐FLAG‐YscD), 
ADMA4101  (His‐FLAG‐YscD,  ΔYscC),  LJM4029  (WT), 






As shown in Table III and Figure 3.1, N-terminal tags do not interfere with the function of 
YscQ. To allow a possible purification of the basal body containing the cytosolic components, 
which could not be obtained with a single tag on YscJ (see previous chapter), a strain was 
generated that expresses both YscJ-His8 and FLAG-YscQ (AD4015, “split-TAP”), which was 




No  membrane  ring  component  is  purified  with  YscQ;  size  exclusion 
chromatography suggests the formation of YscQ tetramers 
TAP was performed using the split-TAP tagged strain AD4015. As a control, strain 
AD40085, harboring both tags at YscJ, was used. Both strains were first purified with a Ni2+ 
affinity column (binding the His8 tag at YscJ), and subsequently with an anti-FLAG column 
(binding the FLAG tag at YscQ or at YscJ, respectively). 
While the first purification step yielded similar results for both strains, no proteins were 
eluted from the anti-FLAG column for the split-TAP strain AD4015 (Figure 4.23). This 
suggests that there is no stable interaction between the C ring and the MS ring under these 
conditions.  
Figure  4.22:  Expression  and 
functionality  of  tagged  YscQ 
variants. 
A:  Immunoblot  analysis  of  cellular 
proteins  using  antibodies  directed 
against  YscJ,  YscQ  and  YscF  in  strains 
MRS40 (WT), AD4014 (His‐FLAG‐YscQ), 
and  AD4015  (YscJ‐His,  FLAG‐YscQ). 
Expected  protein  sizes:  H,  His‐tagged 
protein;  F,  FLAG‐tagged  protein;  HF, 









FLAG affinity purification of strain AD4014 expressing His8-FLAG-tagged YscQ, after 
crosslinking, resulted in specific purification of YscQ without evidence for significant 
copurification of other T3S components (Figure 4.24 A). This result was confirmed by mass 
spectrometry analysis of this sample, which did not detect any T3S component except for 
YscQ itself. 
To determine the oligomeric state of YscQ, analytic size exclusion chromatography was 
performed on purified YscQ obtained by FLAG purification as described above. The resulting 
broad peak corresponded to a molecular weight of 80 – 150 kDa (Figure 4.24 B). This 
suggests the formation of trimers or tetramers (MW(YscQ) = 34.4 kDa). A tetramerization 
property of C ring components has been observed before for HrcQ and FliN (Fadouloglou et 
al., 2004; Brown et al., 2005). As no peak corresponding to a large complex could be 
observed, it is unlikely that the complete C ring was purified under these conditions. This 
result supports the model of an instable or dynamic C ring (see chapter 4.3.3). 
 
Figure 4.23: 
By  TAP,  no  copurification  of  YscJ 
and YscQ can be obtained. 
Immunoblot  analysis  of  purification 
fractions,  using  antibodies  directed 
against  YscJ.  Upper  panel:  Ni2+ 
affinity  purification.  Lower  panel: 
Subsequent  FLAG  affinity 



















Figure  4.24:  Purification  of  His‐FLAG‐YscQ  shows  no  major  copurification  of  other 
injectisome  components;  subsequent  analysis  by  size  exclusion  chromatography  indicates 
the formation of YscQ tetramers. 
A: Silver staining of a FLAG affinity purification of strain AD4014 (His‐FLAG‐YscQ). FT, flow‐through; 
W, washing  steps;  El.,  elution  steps.  The  circle denotes  the  size of  YscQ,  the  asterisk denotes  a 







In the framework of the Sinergia project, several constructs have been generated for 
crystallization and structure determination in the group of Dirk Heinz at the Helmholtz Centre 
for Infection Research, Braunschweig, Germany (Figure 4.25, Table VII). As the structure 
determination is part of the ongoing work in the Sinergia project, this chapter focuses on the 




YscV is a multi-membrane spanning protein. The transmembrane helices are clustered in the 
N-terminus (see Figure 4.25). The C terminus harbors the largest soluble domain among all 
IM export proteins YscR, S, T, U, V, which makes it an interesting candidate for regulatory 
functions. This domain is predicted to be located in the cytosol by most topology prediction 
programs. Recently, the C terminus of the homologue HrcV from Xanthomonas campestris 
















Figure  4.25:  Topology  of  YscD,  YscJ,  and  YscV,  and  schematic  depiction  of  the  proteins 
expressed in the denoted constructs. 
Upper  part:  Phobius  domain  prediction.  Numbers  correspond  to  amino  acid  positions  of  the 
domains  predicted  to  be  located  in  the  respective  compartments,  graphs  depict  the  calculated 
probability of  the prediction. Red,  signal  sequence  (Sig); green, cytosolic domain  (Cyt); gray, TM 






Name  Protein  Expressed domain  Fusion 
(Expression vector) 










pAD154  YscD  putative periplasmic domain (aa 150‐418)  N‐terminal GST‐PreScission 
(pGEX‐6P‐1) 






pAD185  YscJ  putative stable periplasmic domain (20‐195)  N‐terminal His6‐TEV 
(pET‐21b) 
pAD186  YscJ  complete periplasmic domain (aa 20‐217)  N‐terminal His6‐TEV 
(pET‐21b) 
pAD187  YscJ  putative stable periplasmic domain (aa 20‐195)  C‐terminal His6 
(pET‐21b) 
pAD188  YscJ  complete periplasmic domain (aa 20‐217)  C‐terminal His6 
(pET‐21b) 
pADCP197  YscJ  full‐length protein (aa 1‐244)  C‐terminal Gly4‐His6 
(pET‐21b) 





As the most C-terminal transmembrane domain of YscV was predicted to consist of amino 
acids 304-321, the construct pAD148 encodes amino acids 322-704 in the bacterial 
expression vector pGEX-6P-1 with an N-terminal cleavable GST-PreScission tag. 
E. coli harboring pAD148 were used for an expression and purification test. YscV322-704 was 
overexpressed in E. coli Top10 upon induction with 0.2 mM IPTG. A one-step affinity 
purification with Glutathion Sepharose was performed, and the eluted protein was cleaved 
with PreScission protease. The results showed that YscV322-704 can be produced and purified 
from E. coli. The resulting protein was soluble and ran according to its calculated MW on an 






YscV expressed from this construct did not yield suitable crystals (U. Wiesand, personal 
communication). Limited proteolysis resulted in a stable fragment lacking about 30-40 amino 
acids at the N terminus. Sequence analysis and comparison with the flagellar homologue FlhA 
suggested that the cleavage occurs at Ser354 (U. Wiesand, personal communication). 
Therefore, a further construct (pAD172) was cloned expressing amino acids 356-704. Last, 
results from X. campestris (Berger, 2005) showed two further putative transmembrane helices 
in HrcV. Alignment of the two structures predicted the most C-terminal of these helices to 
end at amino acid 414. Although the evidence for these additional transmembrane helices is 
weak, a third construct (pAD173), coding for amino acids 412-704, was constructed to 
exclude the possibility of transmembrane helices preventing crystallization of the construct. 
At present, only two of the constructs, pAD148 and pAD172, could be studied in detail. Both 
proteins were well expressed and soluble. After purification, 5-10 mg protein per liter solution 
could be obtained for pAD148 (Wiesand, 2010). Both constructs unexpectedly showed 
oligomerization properties. While pAD148 led to the formation of various oligomeric species, 
the stable fragment encoded for by pAD172 showed a distinct peak at a Mr of 480 kDa, 

















Asterisk  denotes  cleavage of  the protein  by  addition of  PreScission protease.  TC,  total  cell;  b.i., 






YscD is a bitopic protein predicted to have a shorter N-terminal cytosolic domain (amino 
acids 1-121) and a larger C-terminal periplasmic domain (amino acids 147-418) (Figure 4.25). 
It is less conserved among species than most other basal body components; its role has been 
unclear for a long time. The results of the assembly determination (chapter 3) suggested that it 
might link the two membrane rings. This view is in accordance with recent models based on 
structure determination (Spreter et al., 2009). 
The linking domain in the periplasm would be the C terminus of YscD. To determine the 
structure of this domain, pAD154 was created, which encodes amino acids 150-418 in the 
bacterial expression vector pGEX-6P-1 with an N-terminal cleavable GST-PreScission tag. 
E. coli harboring pAD154 were used for an expression test. YscD was strongly overexpressed 
upon induction with 0.2 mM IPTG and soluble (Figure 4.27). Further purification and 




YscD could be purified in large amounts from plasmid pAD154, was soluble and monomeric 
(U. Wiesand, personal communication). It is being studied in Dirk Heinz’ lab at the moment. 
For a new approach based on the co-crystallization of the membrane ring structures, two 
further YscD constructs were generated, expressing the full-length protein (pADCP199), and 
the putative periplasmic domain including the transmembrane helix (amino acids 120-418, 
pADCP200). 
Figure 4.27: Expression of YscD150‐418. 
Left  side:  Coomassie  staining;  right  side: 
immunoblot  anti‐YscD.  TC,  total  cellular 






YscJ is a bitopic protein that has been suggested to form the MS ring in the IM (Yip et al., 
2005). It has a predicted N-terminal sec signal sequence, a lipid anchor at position Cys-19  
and a TM helix at the very C-terminus, which is not present in all homologues (Michiels et 
al., 1991; Burghout, 2004; Silva-Herzog et al., 2008). 
To determine the structure of the strongly conserved periplasmic domain, several constructs 
have been cloned (Table VII). These constructs cover either the complete periplasmic domain 
or the equivalent of the stable periplasmic domain crystallized in EPEC (Yip et al., 2005) and 
have been fused to either an N-terminal or a C-terminal His tag. 
All four proteins were expressed well and soluble (U. Wiesand, personal communication). 
They are being studied in Dirk Heinz’ lab at the moment. 
For a new approach based on the co-crystallization of the membrane ring structures, two 
further YscJ constructs were generated based on the functional proteins used for the 
copurification of the ring structures in Yersinia (chapter 3). They encode for the full-length 
protein including the signal sequence, fused either to a C-terminal Gly4-His6 tag (pADCP197, 






Substructures of the injectisome have been purified from various organisms, using similar 
protocols that include spheroplast generation, lysis, and differential centrifugation (Kubori et 
al., 1998; Tamano et al., 2000; Sekiya et al., 2001). To obtain copurification of the membrane 
ring proteins of the Y. enterocolitica injectisome, the protocol had to be adapted, and the 
adhesin YadA, which led to aggregation of the spheroplasts, was removed. The resulting 
protocol, which led to consistently good spheroplast generation and lysis, was combined with 
a one-step affinity purification or TAP in strains expressing functional tagged components. 
During the course of this work, the purification of Shigella NCs using a His tag at the YscD 
homologue MxiG (Zenk et al., 2007), illustrated the principal applicability of this approach. 
Surprisingly, a strain co-expressing His-YscD and YscJ-FLAG was non-functional, in 
contrast to strains expressing either of both proteins or even larger tags at the respective 
positions. This finding suggests a close proximity of the N-terminus of YscD and the C-
terminus of YscJ, both located in the cytosol. Recently, this was demonstrated for the 
S. enterica SPI-1 homologues; by crosslinking and mass spectrometry, Schraidt et al. (2010) 
could show that the extreme N-terminus of PrgH (Met-1 and Lys-4) and the extreme C-
terminus of PrgK (Lys-246 and Lys-248) are in close proximity. 
Using tags on either YscD or YscJ, the membrane-ring forming proteins YscC, YscD, and 
YscJ could be copurified, which allowed to determine the assembly order of these 
components (chapter 3). This purification could be slightly improved by adding a second 
purification step. In a more detailed analysis, the copurification of two more proteins could be 
shown: The needle subunit YscF (by immunoblot), and the IM export machinery component 
YscV (by mass spectrometry). The high proportion of the respective tagged component in 
relation to the copurified components, especially YscF, suggests that the purification at least 
to some extent yields monomeric proteins and partially assembled complexes. Especially the 
contact between needle and basal body seems to be fragile. In the few cases, in which 
purification samples were analyzed by electron microscopy, no needle complexes were 
observed. Like it is the case for other bacteria, there was no copurification of cytosolic 
components. This was further confirmed by purification of the tagged C ring component 
YscQ, which yielded tetramers, but no copurification of the membrane ring proteins, in 
agreement with the data obtained for the dynamics of YscQ (chapter 4.3). 
4.4  Supplementary results – Purification of subcomplexes 
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In summary, the modified purification procedure developed in this study can be used for the 
purification of subcomplexes of the injectisome. The limited copurification of the needle 
subunit and an IM component shows that, in principle, the purification of larger parts of the 
injectisome is possible with this protocol. However, for this task, the purity and the ratio of 
fully assembled complexes to monomers have to be increased. 
The preliminary results of the characterization of the cytosolic domain of YscV are discussed 







Genetic alterations in Yersinia enterocolitica, either on the virulence plasmid pYV, or on the 
chromosome, are usually achieved by a two-step homologous recombination. A mutator 
plasmid carrying the altered gene sequence flanked by two homologous regions is first 
integrated into the native genetic environment and subsequently removed (Kaniga et al., 
1991). The second step occurs spontaneously at a low rate, while the strain is propagated for 
36 to 72 hours in non-selective medium, and is selected for sucrose tolerance.14 After removal 
of the mutator plasmid, the resulting clones carry either the wild-type gene or the altered 
gene. If the recombination event would occur randomly in both flanking regions, the ratio of 
clones carrying the mutated gene would be 50%. However, even if the length of the flanking 
regions is identical, the actual mutant ratio is significantly lower in most cases, ranging 
between 10-1 and 10-3. As this makes the generation of mutants a labor- and resource-
demanding task, a method was devised to increase the fraction of mutant strains. 
Yersinia that carry a functional T3S system are impaired in growth in the absence of calcium 
at 37°C (Straley, 1991). Thus, the propagation of the strains after the first recombination 
event was performed in secretion-permissive medium (BHI-Ox) at 37°C (see Material and 
methods for details). Since T3S mutant strains are able to replicate faster under these 
conditions, this approach should increase their ratio. 
By design, this method can only be applied to generate mutant strains that are non-functional 
for type III secretion, such as mutants in the IM export machinery proteins YscR, S, T, U, V. 
Table VIII shows the outcome of the revised protocol in comparison to the traditional method 
to generate such mutants (Kaniga et al., 1991). Ten different clones (five different strains, two 
clones per strain) that had undergone the first recombination event were propagated as 
described above. After three twelve-hour propagation steps, the cultures were plated on agar 
containing sucrose to select for the second recombination event. Colonies were then tested for 
the presence of the wild-type or mutated gene by colony PCR. Using the traditional method, 
only one of 144 tested colonies carried a mutated gene, whereas the improved method yielded 
                                                        




22 mutants out of 120 tested colonies, covering all five strains. The efficiency of the method 












Table VIII:  The  revised method  to generate non‐secreting mutant  strains of Yersinia  significantly 
increases the ratio of mutant colonies 




Analysis  and  complementation  of  single  and  complete mutants  in  YscR,  YscS, 
YscT, YscU, and YscV 
Mutant strains were generated for each of the single proteins YscR, S, T, U, V, as well as for 
all five proteins (see table IX for details). As yscRSTU are located adjacently in the virB 
operon, while yscV is located in another operon, complete deletions were generated by 
deleting yscRSTU in strains already lacking yscV. 
 
Strain names*  Genotype  Secretion  Complementation  C ring formation 
AD4031 / AD4032  ΔyscR ‐  +  decreased  
AD4033 / AD4034  ΔyscS ‐  +  decreased  
AD4035 / AD4036  ΔyscT ‐  +  wild‐type 
LY4001 / AD4026  ΔyscU ‐  +  wild‐type 
AD4037 / AD4038  ΔyscV ‐  +  decreased  
AD4107 / AD4108  ΔyscRSTUV ‐  +  decreased  









As expected, all strains were unable to secrete effector proteins, and could be complemented 
in trans by plasmids expressing the removed protein (pMA19, pMA22, pAD152, pLY7, 





The proteins of the IM export machinery have been proposed to localize to a membrane ring 
within the MS ring, where they would exert their role in substrate recognition (Sorg et al., 
2007) and export; only one copy of each protein would fit into this position. Therefore, it is 
crucial to establish the stoichiometry of the proteins; for this reason, we determined the 
induction level that was required for in trans complementation of each protein. 
Interestingly, strong induction (0.3% arabinose) of YscR, but no other protein, led to cell lysis 
(Figure 4.29) and a low final OD (data not shown). More importantly, the required arabinose 
concentration for an induction level that completely restores effector secretion was about 
0.03% for YscR and YscS. The same concentration of 0.03% was required for YscT and 
                                                        
15 Plasmids pMA19 and pLY7 have a basal expression level even without arabinose induction under the 






















YscU (not shown). However, YscV required an induction level of 0.3% to be expressed at a 




Even though all proteins were cloned in the same way, with the start codon at the identical 
position of the same vector, protein expression does not necessarily directly correlate with the 
arabinose concentration used for induction. Although this experiment therefore only allows 
qualitative statements, the result indicates a higher stoichiometry for YscV than for the other 



























Functionality  and  dominant  negative  effect  of  fluorescently  tagged  protein 
variants 
As the study of fluorescent fusions can help to gain insight into both stoichiometry and 
assembly order, several fusions to the IM export machinery proteins were tested for 
functionality and analyzed under the fluorescence microscope. 
Transmembrane helix predictions in combination with knowledge about the existing fusion 
proteins YscRS (in Y. pestis FV-1; Touchman et al., 2007) and YscTU (in the Chlostridium 
flagellar homologues, also functional in Salmonella; Van Arnam et al., 2004), suggested that 
the C-termini of all five proteins are localized in the cytosol, making them suitable for fusions 
to EGFP, which allows the easier visualization of weak spots in our experimental settings 
(own unpublished data)16. As N-terminal fusions could interfere with the sec signal sequence 
predicted for some of the proteins, all proteins were fused to EGFP at their C terminus. YscT 
and YscV, which have no predicted N-terminal sec signal sequence, were additionally cloned 
as N-terminal EGFP fusions. 
As shown in Figure 4.30 A, the two N-terminal fusions as well as the C-terminal fusions of 
YscR, YscS, and YscV did not restore secretion in the respective mutant strains and were 
therefore considered non-functional. In contrast, YscT-EGFP and YscU-EGFP did 
complement for secretion. 
As non-functional mutants of cooperatively acting multimeric proteins can show a dominant 
negative effect when coexpressed with functional wild-type variants of the proteins, the 
functionality of injectisomes was tested in wild-type strains coexpressing the non-functional 
proteins YscR-EGFP, YscS-EGFP, or YscV-EGFP. However, even at an induction level far 
above the levels required for complementation, no negative effect of any of these fusion 
proteins could be observed (Figure 4.30 B). This implies that the fusion proteins are not or 




16 Recently, a study investigating the topology of the Xanthomonas campestris homologues (Berger et al., 
2010) suggested different topologies for YscR, YscS, and YscT. However, the presented results are at odds 
with the derivations from the fusion proteins and most in silico predictions. At the present stage, the 

















Figure  4.30:  YscT‐EGFP  and  YscU‐EGFP  are  the  only  tested  fusion  proteins  that  are 
functional. The non‐functional EGFP fusions do not show a dominant negative effect. 
A:  Complementation of  effector  secretion  in  the  corresponding mutant  strains by expression of 
fluorescent  fusion  proteins.  Strains:  MRS40  (WT);  AD4031(pAD192)  (ΔYscR  +  pBAD‐yscR‐egfp); 
AD4033(pAD194)  (ΔYscS  +  pBAD‐yscS‐egfp);  LY4001(pAD195)  (ΔYscU  +  pBAD‐yscU‐egfp); 
AD4037(pAD159)  (ΔYscV  +  pBAD‐egfp‐yscV);  AD4037(pAD155)  (ΔYscV  +  pBAD–yscV‐egfp); 
AD4035(pAD160)  (ΔYscT  +  pBAD‐egfp‐yscT);  AD4035(pAD161)  (ΔYscT  +  pBAD‐yscT‐egfp). 
In  trans  expression  of  the  fusion  proteins was  either  not  induced  (n.ind.)  or  induced  by  0.15% 
arabinose  (0.15%).  B:  Coexpression  of  the  non‐functional  fusion  proteins  YscR‐EGFP  (from 







All C-terminal EGFP fusions were tested under the fluorescence microscope. Neither the non-
functional fusions to YscR and YscS, nor the functional fluorescent variants of YscT and 
YscU showed the appearance of fluorescent membrane spots when induced at the level 
required for complementation of secretion (0.03% arabinose) or stronger (0.3%) (data not 
shown). In the case of the functional proteins YscT-EGFP and YscU-EGFP, this indicates a 
stoichiometry within the functional injectisome, which is below the detection limit.17  
In contrast, YscV-EGFP showed the appearance of membrane spots (Figure 4.31), indicating 
a higher stoichiometry of YscV. 
To test for the significance of the YscV-EGFP foci, they were colocalized with YscC-
mCherry. As visible in Figure 4.31 A, there are fewer YscV spots than YscC spots, but YscV 
spots do largely colocalize with YscC spots, suggesting that they can be used as a read-out for 
YscV assembly. 
Further, YscV-EGFP localization was tested in strains lacking either the MS ring component 
YscJ or the ATPase YscN. Lack of YscN did not influence the localization of YscV-EGFP 
(Figure 4.31 B). As, vice versa, lack of YscV does not prevent assembly of YscN (chapter 3), 
this suggests that assembly of YscV occurs independently from the assembly of the ATPase – 
C ring complex. 
Removal of YscJ caused a unique phenotype for YscV-EGFP localization: While fluorescent 
foci were detectable under the microscope, they were highly motile. Figure 4.31 C shows 
series of images taken at the same position in intervals of five seconds. Whereas YscV-EGFP 
spots normally displayed a stable localization, the spots in a strain lacking YscJ quickly 
changed their positions within the bacterial membrane. This suggests that the presence of the 
MS ring is not required for the oligomerization of YscV-EGFP, but for its localization to the 




17 As the fusion proteins could not be detected by immunoblot due to low protein levels and lack of specific 





































Fluorescence  micrograph  showing  pattern  of  YscV‐EGFP  localization  over  time  for  strains 
ADMA4158(pAD155)  (YscC‐mCherry,  ΔYscV  +  pBAD‐yscV‐egfp)  and  AD4160(pAD155)  (ΔYscJ, 
ΔYscV + pBAD‐yscV‐egfp). Note that the z level slightly changes with time due to shrinking of the 






The IM export machinery consists of the five proteins YscR, S, T, U, V. In the determination 
of the assembly order, we found that, while deletion of some of these proteins reduced the 
number of EGFP-YscQ foci, none of them was required for the assembly of the cytosolic 
components. This result was unexpected, considering the proposed localization of the proteins 
within the MS ring. There are three possible explanations for this: (i) YscR, S, T, U, V 
assemble prior to the MS ring in vivo, but there is no checkpoint for their incorporation; 
(ii) they can diffuse laterally into the MS ring; (iii) at least some of the subunits are localized 
outside of the MS ring. All of these explanations have consequences for the function of the 
IM export machinery and the complete injectisome. 
For this reason, we studied the function and localization of these proteins in more detail. As 
expected, all five proteins were essential for secretion, and the deletion strains could be 
complemented by expression of the respective protein in trans. Subsequently, we checked the 
required induction level and the functionality and localization of EGFP fusions to the 
C termini of the proteins. We found that in both cases, YscV displayed a unique behavior 
within the protein family18. It did not only require a substantially higher induction level to 
complement a mutant for effector secretion, but also was the only protein that could be 
detected in spots at the bacterial membrane (even though YscV-EGFP was, as the fusions to 
YscR and YscS, non-functional). 
We thus focused our studies on the role of YscV, the protein with the most TM helices (eight; 
Plano et al., 1991) and the largest soluble domain (> 40 kDa) within the IM export apparatus. 
The flagellar homologue FlhA has been shown to interact with FlhB (YscU), the MS ring 
component FliF (YscJ) and the components of the ATPase complex FliH and FliI (YscL, N) 
(McMurry et al., 2004), but the interactions between these proteins and wild-type FlhA are 
weak (Minamino et al., 2010). Interestingly, a mutation in the cytosolic domain of FlhA 
restored flagellar protein export in a FliH (YscL) deletion mutant (Minamino et al., 2003). 
Our data showing the visibility of YscV-EGFP foci at the membrane and the higher induction 
level required for complementation suggest that YscV is present at a higher stoichiometry  
than the other components of the IM export machinery. Stoichiometry of YscV is a critical                                                         
18 Notably, while FlhB and FlhA are in the same operon in most flagellar systems, YscV is in a separate 
operon in all non-flagellar T3S, except for Chlamydia (Hefty and Stephens, 2007). However, the 
Chlamydia T3S represents an own lineage, that is closely related to the flagellar T3S. Some flagellar genes, 
including FlhA, even interact with injectisome components, including the YscU homologue, in this 
bacterium (Stone et al., 2010). 
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question, as the presence of multiple copies would exclude the proposed localization within 
the MS ring. In agreement with our results, the analysis of the soluble cytosolic domain 
indicated the formation of a dodecamer (Wiesand, 2010), which intriguingly matches the 
rotational symmetry for the MS ring (Hodgkinson et al., 2009). 
In the flagellum, various FlhA mutants show a strong dominant negative effect (McMurry et 
al., 2004; Saijo-Hamano et al., 2004), suggesting a higher stoichiometry. Multimerization was 
demonstrated for the soluble domain of FlhA (Zhu et al., 2002). However, there is conflicting 
evidence; in another publication, a similar part of FlhA was found to be monomeric by 
analytic gel filtration (Saijo-Hamano et al., 2004). 
In a recent publication, the structure of the C-terminal cytosolic domain of the Salmonella 
YscV homologue InvA has been solved (Worrall et al., 2010). It displays a compact structure 
with one of the subunits resembling the E subunit of the peripheral stalk of the archeal A0A1 
ATPase, which shows a possible mode of interaction with YscN. Importantly, this study 
showed that InvA contains a structural “ring building domain”, as has been found in all 
membrane ring-forming injectisome subunits (Spreter et al., 2009), even though no stable 
multimers could be detected in solution (Worrall et al., 2010).19 
We analyzed the localization and function of YscV-EGFP in various strain backgrounds. 
YscV-EGFP did not complement a deletion in YscV, but also displayed no dominant negative 
effect. This suggests that it is less efficiently integrated into assembling injectisomes than the 
WT YscV. As we could not study the stability of the fusion protein so far, the results based on 
localization of YscV-EGFP have to be treated with care. An antibody against YscV is 
currently being produced, which will help to overcome some of these problems. 
YscV-EGFP largely colocalized with YscC-mCherry, indicating that the protein can be used 
for localization studies. Spot formation did not depend on YscN. This suggests an 
independent assembly of YscV and the ATPase – C ring complex (which does not exclude 
subsequent interaction and stabilization, as indicated by the lower number of C ring foci in a 
strain lacking YscV). Strikingly, in a strain lacking the MS ring component YscJ, YscV-
EGFP foci appeared, but were highly motile within the membrane. This is a unique 
phenotype, as all other observed fusion proteins (as well as YscV-EGFP in the presence of 
YscJ) stably localize, indicating that they are anchored within the peptidoglycan layer. Our                                                         
19 Two recent reports on the crystal structure of the cytosolic domain of the flagellar homologue FlhA 
(Moore and Jia, 2010; Saijo-Hamano et al., 2010) show that the overall structure is similar to the one of 




data therefore suggest that YscV-EGFP multimerization does not depend on the presence of 
the MS ring, but that it binds to YscJ, or a protein which depends on YscJ for its localization, 
in wild-type conditions. The copurification of YscV with the MS ring (chapter 4.4) gives 
further evidence for this hypothesis. 
Taken together, our data support a specific role for YscV in the function of the IM export 
apparatus and indicate a higher stoichiometry compared to other members of this subfamily. 
However, in the absence of further data, this interpretation remains highly speculative. The 
localization of the fluorescent YscV might help to pinpoint its localization and the 
requirements therefore. Based on the crystal structure of the homologue InvA, an EGFP 
fusion site less likely to disturb the interactions of YscV with other proteins, and subsequently 
injectisome function in the hybrid strain, might be found. To test for the role of the TM 
helices of YscV, a strain overexpressing only the soluble domain of YscV in a ΔyscV 
background could be assayed for complementation of secretion. 
Obviously, more work is required to uncover the mechanism of the IM export apparatus. 
While the nature of these proteins makes them difficult study objects, rewarding information 
about a central, but so far surprisingly uncharacterized mechanism – recognition and export of 






















The principal goal of my PhD thesis was to determine the assembly order of the Yersinia 
injectisome. We analyzed the requirements for the oligomerization and localization of various 
functional fluorescent injectisome components, covering major substructures of the type III 
secretion system, and combined the findings with data from co-immunoprecipitation 
experiments. Our results show that the assembly of the injectisome is initiated by formation of 
the secretin ring in the outer membrane, and proceeds via stepwise attachment of the MS ring 
components YscD and YscJ in the inner membrane. While assembly of the membrane rings is 
a slow process, the subsequent steps occur within short time. Here we could, for the first time, 
study the assembly of the cytosolic subunits of the injectisome. After completion of the 
membrane rings, the ATPase YscN and the C ring component YscQ can attach, requiring 
each other – but not the ATPase function – and the two interacting proteins YscK and YscL. 
The inner membrane export machinery is not required for these formation steps, and the time 
point of its assembly in vivo is so far unknown. Our results, however, indicate an independent 
assembly, at least for YscV, that depends on the membrane rings, but not on the cytosolic 
components. 
These finding have structural implications, as they show that YscD connects the ring 
structures in the outer and inner membrane formed by YscC and YscJ. This has been recently 
confirmed by integration of crystal structures into medium-resolution overall structures and 
crosslinking analysis (Spreter et al., 2009; Schraidt et al., 2010). However, the exact position 
of the proteins within the basal body differed between these studies. In the light of these new 
findings, insinuating a different architecture of the membrane rings between species, it seems 
worthwhile to apply the copurification procedure presented in this work to determine the 
interactions within the membrane ring proteins by the analysis of crosslinked peptides, in 
order to obtain a detailed structure of the Yersinia injectisome basal body. 
Irrespective of the recent progress in the determination of injectisome structure and assembly, 
the role of the inner membrane export machinery remains the enigma of type III secretion. 
Our data suggest that YscV plays a unique role within this protein family, as it is required in 
larger amounts and possibly forms oligomers. This, however, would be in conflict with its 
proposed site of function within the MS ring. Further studies about the localization and 
assembly of the IM export machinery might present an important step to reveal the 


















The strains used in this study are listed and described in Chapter 7.3. 
 
Genetic constructions 
The plasmids used in this study are listed and described in Chapter 7.4. 
E. coli Top10 used for plasmid purification and cloning and E. coli Sm10 λpir used for 
conjugation were routinely grown on LB agar plates and in LB broth. Ampicillin was used at 
a concentration of 200 µg/ml to select for expression vectors, Streptomycin was used at a 
concentration of 100 µg/ml to select for suicide vectors. Plasmids were generated using either 
Phusion polymerase (Finnzymes, Espoo, Finland) or Vent DNA polymerase (New England 
Biolabs, Frankfurt, Germany). All constructs were confirmed by sequencing using a 3100-
Avant genetic analyzer (Applied Biosystems, Rotkreuz, Switzerland). The oligonucleotides 
used for genetic constructions are listed in Chapter 7.5. 
Mutators for modification or deletion of genes in the pYV plasmids were constructed by 
overlapping PCR using purified pYV40 plasmid as template, leading to 200 – 250 bp of 
flanking sequences on both sides of the deleted or modified part of the respective gene. For 
the mutator strains introducing EGFP, a precursor mutator vector was created as described 
above. Subsequently, the EGFP gene was inserted in frame from plasmid pEGFP-C1 into the 
digested precursor vectors. The respective regions containing the flanking sequences were 
subcloned into the pKNG101 suicide vector. The allelic exchange was selected by plating 
diploid bacteria on sucrose as described previously (1991), with the following modifications: 
After the integration of the mutator plasmid, 5 ml cultures of BHI-Ox were inoculated with 20 
µl of pre-culture and propagated for 12 h at 37°C. This was repeated two more times, before 
plating 0.5 µl of the last culture on LB agar plates containing 5% sucrose. 
Vectors for protein expression in Yersinia or for overexpression in E. coli were constructed 
according to standard cloning procedures. Affinity tags, unless stated otherwise, and the 
FlAsH tag were introduced with the used oligonucleotides. For vectors harboring hybrid 
genes for fluorescent fusion proteins, precursor vectors were generated and EGFP was 
introduced from pEGFP-C1, as described above. pAD166 expressing YscNK175E was 
generated by overlapping PCR using internal primers encoding for the modified protein 
sequence, and selected by colony PCR and sequencing. For the reporter constructs expressing 
3xGFP under the control of various Yersinia promoters,  the regions upstream of the first gene 
in the respective operon (250 – 350 bp) were amplified by PCR and restricted. The resulting 
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promoter sequence fragments were ligated with corresponding restricted fragments of 
pCDFduet-1 (vector backbone) and pOM-3GFP (3xGFP). The resulting clones were for their 
identity by colony PCR and sequencing. 
 
Y. enterocolitica cultures for secretion and microscopy analysis 
Induction of the yop regulon was performed by shifting the culture to 37°C, either in BHI-Ox 
(secretion-permissive conditions) or in BHI + 5 mM CaCl2 (secretion-non-permissive 
conditions) (Cornelis et al., 1987). Expression of the inducible constructs was induced by 
adding 0.05% L-arabinose to the culture just before the shift to 37°C, unless stated otherwise. 
The carbon source was glycerol (4 mg/ml) when expressing genes from the pBAD promoter 
and for ΔyadA strains harboring the YadA mutator pLJM31, and glucose (4 mg/ml) in the 
other cases.  
 
Yop secretion 
Total cell and supernatant fractions were separated by centrifugation at 20,800 g for 10 min at 
4°C. The cell pellet was taken as total cell fraction. Proteins in the supernatant were 
precipitated with trichloroacetic acid 10% (w/v) final for 1 h at 4°C. 
Secreted proteins were analyzed by SDS–PAGE; in each case, proteins secreted by 3 x 108 
bacteria were loaded per lane. Total secreted proteins were analyzed by Coomassie staining of 
12% SDS-PAGE gels. Detection of specific secreted proteins by immunoblotting was done 
using 15% SDS-PAGE gels. For detection of proteins in total cells, proteins from 1 x 108 or 
2 x 108 bacteria were loaded per lane, if not stated otherwise, and proteins were separated on 
15% SDS-PAGE gels before detection by immunoblotting. 
Membranes were blocked in 5% milk powder (Coop, Basel, Switzerland) in PBS for 1 h at 
RT or 12 h at 4°. Immunoblotting was carried out using rabbit polyclonal antibodies (see 
chapter 7.6) with 5% milk powder in PBS, for 1h at RT. Detection was performed with 
secondary antibodies directed against rabbit Ig and conjugated to horseradish peroxidase 
(1:5000 with 5% milk powder in PBS; Dako), before development with ECL 
chemiluminescent substrate (Pierce). 
For the analysis of protein expression and secretion after transient incubation in secretion-
permissive conditions, bacteria were inoculated and T3S was induced as described above. 
After 3 h at 37°C, the OD600 was determined, cells were gently pelleted (2000 g, 2 min), and 
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resuspended in fresh medium (BHI+Ca2+ or BHI-Ox, at 26°C or 37°C) to a final OD600 of 0.4. 
To completely exchange the medium, cells were pelleted and resuspended a second time 
immediately afterwards in the same way. Afterwards, cells were incubated for 3 h in the new 
conditions, and proteins were analyzed as described above. 
 
Needle purification 
Needles were purified from cultures incubated under secretion-permissive conditions, 
essentially as described by Müller et al. (2005). For time course experiments, 48 ml bacteria 
were removed from the 500 ml culture at the given time points. For end point experiments, a 
100 ml culture was used. In both cases, bacteria were harvested by centrifugation (5 min at 
4000 g) and resuspended in 1 ml 20 mM Tris–HCl, pH 7.5. Needle detachment was increased 
by repeated pipetting through a 1 ml pipet tip. Cells were pelleted by centrifugation (5 min at 
4000 g), and the supernatant containing the needles was passed through a 0.45 µm mesh filter 
(cellulose acetate membrane) and then centrifuged for 60 min at 20,800 g. The resulting pellet 
was resuspended in 20 µl or 40 µl (for time course or end-point experiments, respectively) of 
Lämmli buffer, 15 µl of which were analyzed by SDS-PAGE followed by immunoblotting. 
 
Fluorescence microscopy 
For fluorescence imaging, cells were placed on a microscope slide layered with a pad of 2 % 
agarose dissolved in water or PBS. A Deltavision Spectris optical sectioning microscope 
(Applied Precision, Issaquah, WA, United States) equipped with an UPlanSApo 100x/1.40 oil 
objective (Olympus, Tokyo, Japan) and a coolSNAP HQ CCD camera (Photometrics, Tucson, 
AZ, United States) was used to take differential interference contrast (DIC) and fluorescence 
photomicrographs. To visualize GFP and mCherry fluorescence, GFP filter sets (Ex 490/20 
nm, Em 525/30 nm) and mRFP filter sets (Ex 560/40 nm, EM 632/60 nm), respectively, were 
used. DIC frames were taken with 0.3 s and fluorescence frames with 1.0 s exposure time. Per 
image, a Z-stack containing 20 frames per wavelength with a spacing of 150 nm was 
acquired. The stacks were deconvoluted using softWoRx v3.3.6 with standard settings 
(Applied Precision, WA). The DIC frame at the centre of the bacterium and the corresponding 





Three hours after the induction of the T3S system by temperature shift to 37°C, bacteria were 
attached to poly-D-lysine coated cover slips and fixed with 4% para-formaldehyde for 15 min 
at 25°C. Subsequent steps were performed at 4°C: Cells were blocked with 2% BSA in PBS 
for 60 min, incubated with primary antibody for 90 min, and subsequently incubated for 60 
min either with secondary antibody, or with 2% BSA in PBS, where indicated (no sec. ab). 
Microscopy slides were covered with cover slips using Vectashield mounting medium and 
subsequently analyzed. The primary polyclonal rabbit anti-YscF antibody (MIPA 80) was 
first affinity-purified on YscF from purified needles (Müller et al., 2005) from 900 ml culture, 
and subsequently preabsorbed with bacteria lacking YscF. The remaining solution was used 
undiluted with 2% BSA in PBS. The secondary antibody (Texas Red coupled swine anti-
rabbit, Southern Biotech) was diluted 1:150 in 2% BSA in PBS. Further image analysis was 
performed as described above. 
 
Fluorescence recovery after photobleaching (FRAP) 
FRAP experiments were performed as described in Schulmeister et al. (2008). The laser for 
bleaching of the GFP spots emitted light at a wavelength of 488 nm. The laser was focused on 
the smallest possible area and fluorescence was bleached at 10% of the maximal intensity for 




Y. enterocolitica cultures were grown in secretion-non-permissive conditions to an OD600 of 
1.5-2.2. Protein complexes were then stabilized by crosslinking with 0.25% formaldehyde for 
15 min at 37°C. Cells were harvested by centrifugation (15 min at 1500 g, 25°C) and 
resuspended in 1/5 volume of PBS. After a second crosslinking step (0.4% formaldehyde, 15 
min, 25°C) and harvesting as before, spheroplast generation and lysis was performed as 
described by Kubori et al. (1997) and Blocker et al. (2001), with the modifications listed 
below. In short, cells were resuspended in 1/5 original volume of ice-cold spheroplasting 
buffer (0.75 M Sucrose, 50 mM Tris, pH adjusted with HCl to 7.8, 0.6 mg/ml Lysozyme, 6 
mM EDTA), and incubated at 25°C up to 90 min, until complete spheroplast formation could 
be observed. Cells were lysed by addition of 1% Triton X-100 and subsequent incubation at 
4°C for 15 min. After addition of 15 mM MgCl2, unlysed cells were removed by 
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centrifugation (20 min at 6000 g, 4°C). 300 µl of anti-FLAG M2 affinity gel (Sigma-Aldrich, 
Buchs, Switzerland) were added to the supernatant, and the proteins were purified in batch 
according to the manufacturer’s protocol. The elution fractions were recentrifuged to 
completely remove resin, and separated on 12% SDS-PAGE gels or 4-12% gradient SDS-
PAGE gels (Serva, Heidelberg, Germany). Silver Staining was performed as described by 
Blum et al. (1987). Immunoblotting was carried out using rabbit polyclonal antibodies (see 
chapter 7.6), as described above. 
 
Ni2+ affinity purification 
If not indicated otherwise, the Ni2+ affinity purification step in a TAP experiment was 
performed after cell lysis and before FLAG affinity purification. 1 M imidazole (pH 8.0) 
solution was added to the lysate to a final concentration of 30 mM. 1/120 original culture 
volume of Ni2+-loaded Chelating Sepharose FF slurry (GE Healthcare, Amersham, UK) was 
added and the mixture was incubated for 12 h at 4°C in the presence of protease inhibitor 
(Complete EDTA-free, Roche, Basel, Switzerland). The washing and elution steps were 
performed in batch according to manufacturer’s protocol. Proteins binding to the Ni2+ column 
were eluted with buffer containing 500 mM imidazole and the elution fractions wee 
recentrifuged to completely remove resin. 
 
Glutathion affinity purification 
Cell pellets were frozen in liquid nitrogen and stored at -80°C. Before lysis, they were thawed 
on ice, and resuspended in 1/30 original culture volume of resuspension buffer (PBS, 0.2% 
Triton X-100, 1 tablet / 20 ml Complete EDTA-free protease inhibitor). Cells were lysed on 
ice by sonication (70% intensity, 30 intervals à 5 sec, followed by 10 sec intermissions) and 
centrifuged (15,500 x g, 30 min, 4°C). The centrifugation supernatant was filtered through a 
0.45 µm mesh and purified according to manufacturer’s conditions (GE Healthcare). On-bead 
digestion was performed using 15 µl PreScission Protease (GE Healthcare) in 1 ml of 
cleavage buffer (50 mM Tris-HCl pH 7, 150 mM NaCl, 1 mM EDTA, 1 mM DTT) and 




Size exclusion chromatography 
Size exclusion chromatography was performed on a Tricorn 10/600 column hand-packed with 
Sepharose CL-2B resin (GE Healthcare) in SEC running buffer (20 mM Tris-HCl pH 8, 150 
mM NaCl, 0.1% Triton X-100) according to manufacturer’s protocols. The column was 
calibrated for MW determination in the same buffer using the Gel Filtration LMW Calibration 
Kit (GE Healthcare).  
 
Mass spectrometry analysis 
Purification samples for mass spectrometry analysis were reduced by addition of 15 mM DTT 
and incubation at 37°C for 45 min. Afterwards, samples were alkylated by addition of 80 mM 
iodoacetamid at 25°C for 15 min in the dark. To increase protein concentration, a TCA-
Precipitation was performed for (10% v/v final concentration, 4°C, >1 h). The resulting pellet 
was washed twice with ice-cold aceton and resuspended in 10 µl denaturing buffer (100 mM 
Tris pH 8.0, 6 M Urea). The first digest was performed by addition of 1 µl endoproteinase 
Lys C (1h, 37°C). Afterwards, 100 mM Tris-HCl pH 8.0 was added to decrease to urea 
concentration to 2 M. The second digest was performed by addition of 200 ng trypsin and 
incubation at 37°C for 1 h, followed by addition of further 200 ng trypsin and another 
incubation at 37°C for 12 h. 
The samples were analyzed in the lab of Paul Jenö by tandem MS using a LTQ Orbitrap mass 
spectrometer (Thermo Scientific, Waltham, MA, USA). Data processing was done using 
















aa ................................................................................................... Amino acid 
BSA..............................................................................Bovine serum albumin 
CV .......................................................................................... Column volume 
DMSO ................................................................................ Dimethylsulfoxide 
DNA........................................................................... Desoxyribonucleic acid 
DSP ..........................................................Dithiobis[succinimidyl propionate] 
DTT............................................................................................ Dithiothreitol 
E. coli ..................................................................................... Escherichia coli 
ECL ................................................................. Enhanced chemoluminescence 
EDTA............................................................ Ethylenediaminetetraacetic acid 
EHEC ..................................................... Enterohemorrhagic Escherichia coli 
EGFP........................................................Enhanced green fluorescent protein 
EM................................................................................... Electron microscopy 
EPEC.........................................................Enteropathogenic Escherichia coli 
FA ......................................................................................Para-formaldehyde 
FACS.........................................................Fluorescence activated cell sorting 
FITC.................................................................... Fluoresceine-isothiocyanate 
FRAP.......................................... Fluorescence recovery after photobleaching 
FRET...........................................................Förster resonance energy transfer 
g.................................................................Gravitational acceleration constant 
GFP ......................................................................... Green fluorescent protein 
h............................................................................................................Hour(s) 
HBB ......................................................................................Hook-basal body 
IF .....................................................................................Immunofluorescence 
Ig ........................................................................................... Immunoglobulin 
IM........................................................................................... Inner membrane 
IP .....................................................................................Immunoprecipitation 
kDa.................................................................................................. Kilodalton 
min ................................................................................................... Minute(s) 
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mRNA ................................................................................... Messenger RNA 
MS ......................................................................................Mass spectrometry 
MS ring..........................................................Membrane/supramembrane ring 
MW ......................................................................................Molecular weight 
NC ..........................................................................................Needle complex 
Ni-NTA ...............................................Nickel-nitrilo tetra-acetic acid agarose 
nr ...............................................................................................non-redundant 
o/n....................................................................................................Over night 
OD600 .......................................................................Optical density at 600 nm 
OM ........................................................................................ Outer membrane 
ORF .................................................................................. Open reading frame 
P. aeruginosa ..........................................................Pseudomonas aeruginosa 
P. syringae................................................................... Pseudomonas syringae 
PAGE .......................................................Polyacrylamide gel electrophoresis 
PBS..........................................................................Phosphate buffered saline 
PCR ........................................................................Polymerase chain reaction 
PMF..................................................................................Proton-motive force 
PP ..................................................................................................... Periplasm 
pYV ...................................................................Plasmid of Yersinia virulence 
RNA ...................................................................................... Ribonucleic acid 
rpm ..............................................................................Revolutions per minute 
RT....................................................................................... Room temperature 
S. enterica.........................................................................Salmonella enterica 
S. flexneri................................................................................Shigella flexneri 
SDS ............................................................................ Sodium dodecyl sulfate 
sec..................................................................................................... Second(s) 
SPI-1...........................................................Salmonella pathogenicity island 1 
SPI-2...........................................................Salmonella pathogenicity island 2 
T3S ...................................................................................... Type III secretion 
TAP .................................................................... Tandem-affinity purification 
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TCA................................................................................. Trichloro acetic acid 
TEM .......................................................... Transmission electron microscopy 
TM.......................................................................................... Transmembrane 
Tris .......................................................... Tris(hydroxymethylaminomethane) 
WT ................................................................................................... Wild-type 
Y. enterocolitica ...........................................................Yersinia enterocolitica 
Y. pestis .....................................................................................Yersinia pestis 
Y. pseudotuberculosis ......................................... Yersinia pseudotuberculosis 
 
According to the suggestions of the IUPAC-IUB Joint Commission on Biochemical 






Sequence homology searches were performed with BLAST (Altschul et al., 1990). 
Primers were designed using Primer3 (Rozen and Skaletsky, 2000). 
Protein analyzes 
Protein parameters were analyzed with the ExPASy ProtParam tool (Wilkins et al., 1999). 
Topology predictions were done with Phobius (Kall et al., 2004). 
Image processing 
Stacks of fluorescence micrographs were deconvoluted using softWoRx v3.3.6 with standard 
settings (Applied Precision, Issaquah, WA, USA). 
Image analysis and processing was done using ImageJ (US National Institutes of Health, 
Bethesda, MD, USA) and Photoshop CS4 (Adobe, San Jose, CA, USA). 
Mass spectrometry 
Mass spectrometry data were analyzed and filtered using Mascot (Matrix Science, Boston, 




pYV plasmids based on pYV227 were used in KNG22703 (Kaniga et al., 1991), which is an 
ampicillin sensitive derivate of strain W22703 (Cornelis and Colson, 1975). 
pYV plasmids based on pYV40 were used in MRS40, which is an ampicillin sensitive 
derivate of strain E40 (Sory et al., 1995). 
Yersinia strain names correspond to the name of the pYV plasmid (AD4016 = 
MRS40(pAD4016)). 
 




























































































































































































































Chapter 3 – Deciphering the assembly of the Yersinia type III secretion injectisome 




















































































Chapter 4.2 – Regulation of expression and function of the Yersinia type III secretion 
system 





























Chapter 4.3 – Kinetics and dynamics of the Yersinia type III secretion system 




















































































Chapter 4.4 – Purification of subcomplexes of the injectisome 




































Chapter 4.5 – The type III secretion “IM export machinery” 










































No.  Sequence  Features  Used for cloning of  Template 
4462  catggtcgacaaaactgaatccagctcaacg SalI site  pAD3, ext. fwd. primer  pYV40 
4463  agtaattggtgagcatgagttattatgcgtgcgatg   pAD3, int. rev. primer  pYV40 
4464  acgcataataactcatgctcaccaattacttcttaatgg   pAD3, int. fwd. primer  pYV40 
4465  catgtctagatggctcatcccattgaatct XbaI site  pAD3, ext. rev. primer  pYV40 
4523  gatcgggcccttcagtttgacacctacatacctca ApaI site  pAD104, pAD106, 
pAD110, ext. fwd. primer 
pYV40 

























4762  gatcgggccctgaattgggggctattatg ApaI site  pAD114, pAD116, 
pAD118, ext. fwd. primer 
pYV40 






















4768  tatggatccggtggagcaggtggtgccggaggtagtttgttaaccttgccacaagc   pAD118, int. fwd. primer  pYV40 
4641  gactaagcttggtcaaccctctcttttcca HindIII site  pAD123  pYV40 
4675  gatcggatccataaatgttatactgtcctaaaaatctaa SacI site    pYV40 
4643  gactaagctttggcaatgtcgatgtactgg HindIII site  pAD124  pYV40 
4676  gatcggatccataatctacctcctattttattacgttattt SacI site    pYV40 
4645  gactaagcttactggcaatctctggatgct HindIII site  pAD125  pYV40 
4677  gatcggatccataaatccataatggttgaaatattaa SacI site    pYV40 






4929  gatcgggcccgaaccaacttccggttcaag ApaI site  pAD128 and pAD170, ext. 
fwd. primer 
pYV40 
4930  ccagcccatgcgtcatgaaatcgtaacctctgtca   pAD128, int. rev. primer  pYV40 
4931  ttacgatttcatgacgcatgggctggtgatta   pAD128, int. fwd. primer  pYV40 
4932  gatctctagaagcaaacagtgtgaccacca XbaI site  pAD128, ext. rev. primer  pYV40 
4933  gatcgggcccctgcgtttacggtgagtgag ApaI site  pAD130, ext. fwd. primer  pYV40 
4934  aagccacgaggcgtcaccctccgtaactaatcacc   pAD130, int. rev. primer  pYV40 
4935  tacggagggtgacgcctcgtggcttggtaatg   pAD130, int. fwd. primer  pYV40 
4936  gatctctagaagacataaagagccaatgaacagac XbaI site  pAD130, ext. rev. primer  pYV40 
4937  gatcgggccctggctggtgctagtcctttc ApaI site  pAD132, ext. fwd. primer  pYV40 
4938  cagtaaacttatagtcatcttatgccttgtatcttcatc   pAD132, int. rev. primer  pYV40 
4939  aaggcataagatgactataagtttactgatccctgttttgg   pAD132, int. fwd. primer  pYV40 
4940  gatctctagactctgctctgcggggatta XbaI site  pAD132, ext. rev. primer  pYV40 
4941  gatcgggcccgctgacgttaaatcctgagca ApaI site  pAD134, ext. fwd. primer  pYV40 
4942  agtaccggcaagtcatggggattcattatgatcttt   pAD134, int. rev. primer  pYV40 
4943  tgaatccccatgacttgccggtactttcatacca   pAD134, int. fwd. primer  pYV40 
4944  gatctctagaggataagcacgatccaaacc XbaI site  pAD134, ext. rev. primer  pYV40 
4858  gatcgggccctggtcaggatctacgtactggt ApaI site  pAD136, pAD138, 
pAD140, ext. fwd. primer 
pYV40 






















4864  tatgaattctggtggagcaggtggtgccggaggtagttgggtctgtcgtttttatca   pAD140, int. fwd. primer  pYV40 
5151  gactgaattccgtaagcagagtcgtaatgacg EcoRI site  pAD148  pYV40 
5152  gactctcgagcatcataagcaaactcgtccaa XhoI site  pAD148, pAD172, 
pAD173 
pYV40 
5168  gactccatggggatagcggatttaatccaaagac NcoI site  pAD152 and pAD161  pYV40 
5169  gactaagcttctccgctcattacttctcca HindIII site  pAD152 and pAD160  pYV40 
5170  gactccatggggaatccccatgatcttgagtg NcoI site  pAD153 and pAD155  pYV40 
5171  gactaagcttagggtcttccatcataagcaaa HindIII site  pAD153 and pAD159  pYV40 
5174  gactggatccaaccaggatggacaacttgtt BamHI site  pAD154  pYV40 
5175  gactctcgagaattgtgtcatcgaggtttacc XhoI site  pAD154  pYV40 
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5176  gactaagcttaagaattcgactgctagccataagcaaactcgtccaagtg HindIII site  pAD155  pYV40 
4528  gatcgggccctgcggcaatgtcagaagata ApaI site  pAD158, ext. fwd. primer  pYV40 
5079  ttgcgttgtaacctagttctcacccccccttc   pAD158, int. rev. primer  pYV40 
5080  gggtgagaactaggttacaacgcaagaagtgatg   pAD158, int. fwd. primer  pYV40 




5196  gactccatggagctagcgactgaattcgatagcggatttaatccaaagac NcoI site  pAD160  pYV40 
5197  gactaagcttaagaattcgactgctagcttctccaaaacagggatcagt Hind III site  pAD161  pYV40 
4925  gatcgggcccgatgaaatatctaatcaaagcactacc ApaI site  pAD164, ext. fwd. primer  pYV40 
4926  cacaaattcccgtttcacaatacgccacgcttag   pAD164, int. rev. primer  pYV40 
4927  tggcgtattgtgaaacgggaatttgtgatccag   pAD164, int. fwd. primer  pYV40 
4928  gatctctagatcctgctacataatgaataatggcta XbaI site  pAD164, ext. rev. primer  pYV40 
5275  gactacatgttgtcactagatcagatacctcatcatattcgt PciI site  pAD165 and pAD166, ext. 
fwd. primer 
pYV40 












5271  gactgggcccagcggggtattgccataag ApaI site  pAD168, ext. fwd. primer  pYV40 
5272  ctcattgaaatggagcataaatccataatggttgaaat   pAD168, int. rev. primer  pYV40 
5273  atggatttatgctccatttcaatgagacgctga   pAD168, int. fwd. primer  pYV40 
5274  gacttctagactttacaattcagtgtggtgttttt XbaI site  pAD168, ext. rev. primer  pYV40 
5297  ttttgcctttctatcatgaaatcgtaacctctgtca   pAD170, int. rev. primer  pYV40 
5298  gttacgatttcatgatagaaaggcaaaatatcgagaaaca   pAD170, int. fwd. primer  pYV40 
5299  gatctctagatcctaatataagtgaacctcttgttgg XbaI site  pAD170, ext. rev. primer  pYV40 
5310  gactgaattcgcaaacaagggccgacta EcoRI site  pAD172  pYV40 









5625  gactgagctcattgacgaacatctaccgatgg SacI site  pAD185  pYV40 
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5626  gactgagctcaacgcccttttgactcttcac SacI site  pAD186  pYV40 
5624  gactcatatgaaagttgatctttataccggaattag NdeI site  pAD187 and pAD188  pYV40 
5627  gactgagctcaatggtgatggtgatgatgttgacgaacatctaccgatgg SacI site  pAD187  pYV40 




5710  gactacatgtccgactacaaggacgacgatgataagcaccaccatcaccatcaccatcacgg PciI site  pAD190  pYV40 
5629  gactccatggtccagttaccggatgaaatta NcoI site  pAD192  pYV40 
5751  gactctgcaggcggccgcatcagagctcccctccgtaactaatcaccag SacI site  pAD192  pYV40 
5752  gactccatgggtcaaggtgacataattcacttcac NcoI site  pAD194  pYV40 
5754  gactctgcaggcggccgcatcagagctctcttatgccttgtatcttcatcatgg SacI site  pAD194  pYV40 
3724  gatcccatggccagcggagaaaagacagag NcoI site  pAD195  pYV40 
5755  gactctgcaggcggccgcatcagagctctaacatttcggaatgctgtttc SacI site  pAD195  pYV40 
5965  gactcatatgaaagttaagacttcactgtcaaca NdeI site  pADCP197 and pADCP198 
pAD40082, 
pAD40085 
5966  gactgagctccctcagtgatggtgatggtg SacI site  pADCP197 and pADCP198  pAD40082, 
pAD40085 
5967  gactggatccatgagttgggtctgtcgttttt BamHI site  pADCP199  pYV40 
5969  gactctcgagtgctcctctaattgtgtcatcg XhoI site  pADCP199 and pADCP200  pYV40 




No.  Specificity  Donor organism  Dilution  Source 
  57  anti‐YscP (polyclonal)  rabbit  1:3000  (1) 
  66  anti‐YscJ (polyclonal)  rabbit  1:5000  (1) 
  73  anti‐YopE  rabbit  1:1000  (1) 
  80  anti‐YscF aa 1‐21 (polyclonal)  (2)  rabbit  (3)  (1) 
163  Texas red anti‐rabbit Ig  swine  1:150  (4) 
168  HRP anti‐rabbit Ig  swine  1:5000  (5) 
189  anti‐YscN (polyclonal)  rabbit  1:1000  (1) 
220  anti‐LcrV (polyclonal)  rabbit  1:2000  (1) 
221  anti‐YscU (polyclonal)  rabbit  1:1000  (1) 
223  anti‐YscF (polyclonal)  (6)  rabbit  1:1000  (1) 
227  anti‐YscV aa 133‐200 (polyclonal)  rabbit  1:2000  (1) 
231  anti‐GFP  rabbit  1:800  (7) 
232  anti‐YscD (polyclonal)  rabbit  1:1000  (1) 
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